var title_f9_10_9376="Auricular cellulitis";
var content_f9_10_9376=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Auricular cellulitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 269px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 19-month-old child with a red, swollen, anteriorly displaced auricle after 10 days of treatment with amoxicillin. The posterior aspect of his auricle was erythematous, but his mastoid process was nontender, and his tympanic membrane was normal. Computed tomography demonstrated normal mastoid air cells, and his cellulitis responded to antistaphylococcal antibiotics.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig W, Baskin MN. Atlas of Pediatric Emergency Medicine. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9376=[""].join("\n");
var outline_f9_10_9376=null;
var title_f9_10_9377="Cefsulodin: International drug information";
var content_f9_10_9377=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cefsulodin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Monaspor (AT, CZ, NL);",
"     </li>",
"     <li>",
"      Pseudocef (AT, DE, JP);",
"     </li>",
"     <li>",
"      Pyocefal (FR);",
"     </li>",
"     <li>",
"      Takesulin (JP);",
"     </li>",
"     <li>",
"      Ulfaret (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1978229\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Cefsulodin Sodium",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Cephalosporin (Third Generation)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of susceptible bacterial infections caused by",
"     <i>",
"      Pseudomonas aeruginosa",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: I.M., I.V.: 3-6 g/day in 4 divided doses",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, powder for reconstitution, as sodium: 1 g",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10354 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-64F316EBC0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9377=[""].join("\n");
var outline_f9_10_9377=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303684\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978229\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978231\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978234\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978230\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821187\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978233\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10354\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10354|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_10_9378="Chapter 4D: Tamm-Horsfall mucoprotein";
var content_f9_10_9378=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 4D: Tamm-Horsfall mucoprotein",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9378/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9378/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9378/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9378/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9378/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9378/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9378/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/10/9378/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 12, 2004.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The thick ascending limb secretes a protein called Tamm-Horsfall mucoprotein (THMP) or uromodulin [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. THMP is a membrane protein that is principally located on the luminal surface of the cell membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The function of THMP is unclear. It may have some immunomodulatory activity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/1,2\">",
"     1,2",
"    </a>",
"    ] and may protect against urinary tract infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/4\">",
"     4",
"    </a>",
"    ]. THMP binds specifically to type 1 fimbriated Escherichia coli, the main cause of urinary tract infection, and may diminish adherence of the organism to the urothelium, an important step in the generation of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16102?source=see_link\">",
"     \"Bacterial adherence and other virulence factors for urinary tract infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    THMP is important clinically because it represents the matrix of all urinary casts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/6\">",
"     6",
"    </a>",
"    ]. The casts may contain only the matrix (hyaline casts) or can include degenerated cells or filtered proteins (granular casts), or intact cells that are present in the tubular fluid (red, white, or epithelial cell casts) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/7\">",
"     7",
"    </a>",
"    ]. The type of cast that is present often has important diagnostic implications, e.g., red cell casts are virtually pathognomonic of glomerulonephritis or vasculitis. In contrast, hyaline or granular cast formation is not necessarily indicative of renal disease, since it can be seen in physiologic states such as exercise or fever [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    THMP has been implicated in the pathogenesis of cast nephropathy, a form of renal failure associated with multiple myeloma in which dense intratubular casts occlude the flow of urine. Only some light chains appear to have this property, which seems to require coaggregation with THMP [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22551?source=see_link\">",
"     \"Pathogenesis and diagnosis of myeloma cast nephropathy (myeloma kidney)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon positional clonal techniques, mutations in the gene that encodes for the THMP were found to underlie the following autosomal dominant disorders: typical familial juvenile hyperuricemic nephropathy and type 2 medullary cystic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. These two disorders, which are characterized by hyperuricemia, medullary cysts, interstitial nephritis, and progressive renal failure, are most likely variants of the same underlying physiologic disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/10\">",
"     10",
"    </a>",
"    ]. Although speculative, these mutations probably disrupt the tertiary structure of the THMP, resulting in both disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33721?source=see_link&amp;anchor=H2#H2\">",
"     \"Autosomal dominant interstitial kidney disease (medullary cystic kidney disease)\", section on 'Uromodulin-associated kidney disease (UAKD)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has also been suggested that THMP plays an etiologic role in other disease states such as the inflammatory response in interstitial nephritis. Tubular injury in this setting may lead to the release of THMP, which can then attract neutrophils by binding to specific receptors on the cell surface of the neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9378/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/59/32694?source=see_link\">",
"     \"Chapter 5A: Distal tubule and connecting segment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/1\">",
"      Kumar S, Muchmore A. Tamm-Horsfall protein--uromodulin (1950-1990). Kidney Int 1990; 37:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/2\">",
"      Hession C, Decker JM, Sherblom AP, et al. Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines. Science 1987; 237:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/3\">",
"      Malagolini N, Cavallone D, Serafini-Cessi F. Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein. Kidney Int 1997; 52:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/4\">",
"      Bates JM, Raffi HM, Prasadan K, et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004; 65:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/5\">",
"      Pak J, Pu Y, Zhang ZT, et al. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 2001; 276:9924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/6\">",
"      Rutecki GJ, Goldsmith C, Schreiner GE. Characterization of proteins in urinary casts. Fluorescent-antibody identification of Tamm-Horsfall mucoprotein in matrix and serum proteins in granules. N Engl J Med 1971; 284:1049.",
"     </a>",
"    </li>",
"    <li>",
"     Rose, BD. Pathophysiology of Renal Disease, 2d ed, McGraw-Hill, New York, 1987, p. 82.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/8\">",
"      Huang ZQ, Sanders PW. Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein. J Clin Invest 1997; 99:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/9\">",
"      Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002; 39:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/10\">",
"      Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 2003; 42:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9378/abstract/11\">",
"      Thomas DB, Davies M, Peters JR, Williams JD. Tamm Horsfall protein binds to a single class of carbohydrate specific receptors on human neutrophils. Kidney Int 1993; 44:423.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7285 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-7B5B02C4AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9378=[""].join("\n");
var outline_f9_10_9378=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33721?source=related_link\">",
"      Autosomal dominant interstitial kidney disease (medullary cystic kidney disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16102?source=related_link\">",
"      Bacterial adherence and other virulence factors for urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/59/32694?source=related_link\">",
"      Chapter 5A: Distal tubule and connecting segment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22551?source=related_link\">",
"      Pathogenesis and diagnosis of myeloma cast nephropathy (myeloma kidney)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_10_9379="Alveolar proteinosis chest xray";
var content_f9_10_9379=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary alveolar proteinosis chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows large perihilar and lower lobe opacities with normal cardiac silhouette.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9379=[""].join("\n");
var outline_f9_10_9379=null;
var title_f9_10_9380="Reticulated pigmented anomaly of the flexures";
var content_f9_10_9380=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77681&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77681&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Reticulated pigmented anomaly of the flexures (Dowling-Degos disease)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A reticulated, hyperpigmented plaque is present perianally.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9380=[""].join("\n");
var outline_f9_10_9380=null;
var title_f9_10_9381="Shoulder internal rotation exercise with weight";
var content_f9_10_9381=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1140px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/86075/Sh_inter_rotat_weight_video.mp4?title=Shoulder+internal+rotation+exercise+with+weight\" style=\"width:496px;height:288px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Shoulder internal rotation exercise with weight",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Internal rotation exercises to strengthen the subscapularis muscle can be performed against resistance provided by tubing or weights, as in this video.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Craig Parsons, MS, PT and the Physical Therapy Network.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9381=[""].join("\n");
var outline_f9_10_9381=null;
var title_f9_10_9382="Nitroglycerin (glyceryl trinitrate): Patient drug information";
var content_f9_10_9382=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(true",
"	);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <!-- TC:DRUG_DISCLAIMER -->",
" <div id=\"drugDisclaimDialog\">",
"  <div id=\"drugLogo\">",
"  </div>",
"  <p align=\"left\">",
"   This product is intended to serve as a",
"			rapidly accessible, concise initial reference resource and not as",
"			a complete reference resource. It does not include information",
"			concerning every therapeutic agent, laboratory or diagnostic test",
"			or procedure available. The product is clinically oriented and is",
"			intended to be used only by licensees who are: (1) researchers",
"			who will not use the information for medical diagnosis or",
"			treatment, and (2) physicians and other competent healthcare",
"			professionals who will rely on their own discretion and judgment",
"			in medical diagnosis and treatment.",
"  </p>",
"  <p align=\"left\">",
"   Neither Lexicomp nor",
"			UpToDate directly or indirectly practice medical services and, as",
"			such, assumes no liability for data contained herein. The",
"			licensee assumes full responsibility for the appropriate use of",
"			medical information contained in the product and agrees to hold",
"			Lexicomp, UpToDate and its third-party providers harmless from",
"			any and all claims or actions arising from licensee's use of the",
"			product.",
"  </p>",
"  <p align=\"left\">",
"   UpToDate, Lexicomp and their third-party providers",
"			deliver in \"AS IS\" CONDITION WITH NO WARRANTY",
"			PROVIDED OR ASSUMED, this Database, and documentation describing",
"			it. THIS WARRANTY IS IN LIEU OF ANY AND ALL",
"			OTHER WARRANTIES, WRITTEN OR ORAL, EXPRESS OR IMPLIED, INCLUDING",
"			WITHOUT LIMITATION, WARRANTIES OR MERCHANTABILITY OR WARRANTIES",
"			OF FITNESS FOR A PARTICULAR PURPOSE, ALL OF WHICH UPTODATE AND",
"			LEXICOMP DISCLAIM.",
"  </p>",
"  <a href=\"#\" id=\"lexiInteractClose\">",
"   Click here to continue",
"  </a>",
" </div>",
" <div id=\"drugDisclaimMask\">",
" </div>",
" <!-- TC:SLA_MESSAGE -->",
" <div id=\"slaMessageContainer\">",
"  <div id=\"closeMessage\">",
"   <a href=\"\" id=\"close\">",
"    Close",
"   </a>",
"  </div>",
"  <div id=\"slaMessage\">",
"   The use of UpToDate is subject to the",
"   <a href=\"#\" id=\"sla_message\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <br/>",
"  <div id=\"drugDisclaimMessage\">",
"   Lexicomp drug information &amp; Lexi-Interact are subject to the",
"   <a href=\"#\" id=\"drug_message\">",
"    Lexicomp License Agreement",
"   </a>",
"   .",
"  </div>",
" </div>",
" <div id=\"slaDialog\">",
"  <div id=\"slaDialogTitle\">",
"   Subscription and License Agreement&nbsp;",
"   <a class=\"icontxt\" href=\"./license?view=print\" onclick=\"\" target=\"_blank\">",
"    <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\">",
"     Print",
"    </img>",
"   </a>",
"  </div>",
"  <div id=\"boxDialog\">",
"   <strong class=\"largeGreenHeader\">",
"    Subscription and License Agreement",
"   </strong>",
"   <p>",
"    By clicking the \"accept\" button (or opening and using",
"the software/content package if applicable), you agree to become bound",
"by the terms of this Subscription and License Agreement (the",
"\"Agreement\"). If you do not agree to these terms, if using the",
"online version of UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    software/content, click \"decline\"",
"or do not open the package (and promptly return it). READ THE FOLLOWING",
"TERMS IN THIS AGREEMENT CAREFULLY BEFORE INDICATING YOUR ACCEPTANCE. In",
"this Agreement, the term \"you\" refers to: (i) an entity",
"entering into this Agreement for use of its employees, (ii) an",
"individual purchasing an UpToDate subscription under this Agreement,",
"either on his or her own behalf (or as agent for a corporation or other",
"entity or organization); or (iii) an individual entering into this",
"Agreement as a condition of using UpToDate through a subscription",
"purchased by a hospital, medical school, or other institution",
"(\"Institution\"), where the individual is employed by or",
"affiliated with the Institution.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"LICENSE: UpToDate, Inc. (\"UpToDate\"), in consideration of the",
"subscription fee and acceptance of this Agreement, grants you a",
"non-exclusive, non-transferable license and right to use and access the",
"UpToDate database and software (the \"Licensed Materials\") in",
"accordance with the applicable subscription terms (as may be provided in",
"UpToDate&amp;apos;s separate invoice terms):",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"INDIVIDUAL: An individual subscription permits one individual to access",
"and use the Licensed Materials for his or her own use only by loading",
"the software on a single computer (i.e., within a single CPU) at a fixed",
"location, by loading the PDA software on a single Personal Digital",
"Assistant (PDA), or by using his or her unique user name and password to",
"access the Licensed Materials from any location via the Internet.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"STANDALONE WORKSTATION: A standalone subscription permits multiple users",
"employed by or affiliated with you to access and use the Licensed",
"Materials only for a purpose related to your business by loading the",
"software on a single computer (i.e., within a single CPU) owned or",
"controlled by you, with a hard drive owned or controlled by you",
"connected directly to such computer. You may not install the software on",
"more than one computer. A Standalone Workstation license does not",
"include Internet access to the Licensed Materials.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"INSTITUTIONAL SUBSCRIPTION: An Institutional Subscription permits only",
"individuals who are employed by or affiliated with the relevant",
"institution to access and use the Licensed Materials at any",
"Internet-connected computer validated for such use by UpToDate, but only",
"for the clinical, educational or research purposes of the Institution.",
"Further, access may be restricted to particular websites per the",
"applicable invoice terms.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"OWNERSHIP: The Licensed Materials, including without limitation all",
"copyrights and other intellectual property rights therein, are the sole",
"and exclusive property of UpToDate (or its parents, subsidiaries,",
"affiliates, or designees) or its suppliers. By indicating that you",
"accept these terms, you do not become the owner of the Licensed",
"Materials, but are entitled to use them only according to the terms of",
"this Agreement.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"PERMITTED USES: You may print out, or email to a colleague, individual",
"articles containing only insubstantial portions of the most current",
"version of the Licensed Materials, but only for a) your personal",
"clinical, educational or research use; b) teaching healthcare",
"professionals; or c) consulting with individual colleagues, provided",
"that any printed or emailed articles include a source reference to",
"UpToDate and its copyright notice. You are not permitted to print or",
"email substantial portions of the Licensed Materials, nor to email",
"individual articles to large numbers of recipients.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"PROHIBITED USES: Except as expressly permitted in this Agreement, any",
"copying, distribution or modification of the Licensed Materials is",
"strictly prohibited. No part of the Licensed Materials may be copied for",
"resale or other commercial use, or posted on public bulletin boards, web",
"sites, Internet domains, or online chatrooms. No part of the Licensed",
"Materials may be reverse engineered or included in other software.",
"UpToDate electronically monitors compliance with this Agreement, and",
"reserves the right in its sole discretion to change and or cancel an",
"individual's user name and password or to disable an IP address without",
"notice in the event of multiple concurrent logins, excessive search",
"quantities or excessive download traffic volumes. You agree to comply",
"with all applicable laws, including all US export laws and regulations,",
"in connection with the Licensed Materials.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"SUBSCRIPTION TERM: You have obtained the right to use and access the",
"Licensed Materials for a specific limited period of time, i.e., the",
"subscription period for which you or your Institution have agreed to pay",
"subscription fees. At the end of this period, your license and your",
"associated rights, such as technical support, will expire automatically,",
"unless you or your Institution have renewed your subscription on",
"UpToDate's then-current terms. UpToDate may embed technology in the",
"Licensed Materials causing them to become inaccessible after your",
"subscription term. The Agreement and your license to use the Licensed",
"Materials will also terminate if you fail to comply with any term or",
"condition in this Agreement.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"RESTRICTION AGAINST TRANSFER: You may not sublicense, assign, share,",
"sell, rent, lease, or otherwise transfer your right to use the Licensed",
"Materials (including your username and password) whether by merger,",
"operation of law, or otherwise.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"USE OF PROFESSIONAL JUDGMENT: The editors and authors of the Licensed",
"Materials have conscientiously and carefully tried to create the",
"identified diagnosis measures, treatment alternatives and drug dosages",
"in the Licensed Materials that conform to the standards of professional",
"practice that prevailed at the time of publication. However, standards",
"and practices in medicine change as new data become available and the",
"individual medical professional should consult a variety of sources. For",
"this reason, only the most current release of the Licensed Materials",
"should be consulted when information is sought. New updates of the",
"Licensed Materials are issued periodically; do not rely on older",
"versions. In addition, when prescribing medications, the user is advised",
"to check the product information sheet accompanying each drug to verify",
"conditions of use and identify any changes in dosage schedule or",
"contraindications, particularly if the agent to be administered is new,",
"infrequently used or has a narrow therapeutic range.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"The Licensed Materials describe basic principles of diagnosis and",
"therapy. The information provided in the Licensed Materials is no",
"substitute for individual patient assessment based upon the healthcare",
"provider's examination of each patient and consideration of laboratory",
"data and other factors unique to the patient. The Licensed Materials",
"should be used as a tool to help the user reach diagnostic and treatment",
"decisions, bearing in mind that individual and unique circumstances may",
"lead the user to reach decisions not presented in the Licensed",
"Materials. The opinions expressed in the Licensed Materials are those of",
"its authors and editors and may or may not represent the official",
"position of any medical societies cooperating with, endorsing or",
"recommending the Licensed Materials.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"LIMITED RIGHTS NOTICE. Any access to the Licensed Materials provided",
"under contract to the Government are provided with limited rights. The",
"Licensed Materials may be reproduced and used by the Government with the",
"express limitation that they will not, without written permission of",
"UpToDate, be used for purposes of manufacture nor disclosed outside the",
"Government. The term \"Government\" as used herein shall have",
"the meaning ascribed to it in 48 CFR 52.227-14.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"LIMITED WARRANTY: If UpToDate has supplied physical media to you",
"containing the Licensed Materials and they are defective, such media",
"will be replaced without charge if returned to the place of purchase",
"within 60 days after date of payment of the license fee. EXCEPT AS SET",
"FORTH IN THE FOREGOING SENTENCE, NEITHER UPTODATE NOR ANY OTHER PARTY OR",
"MEDICAL SOCIETY MAKES ANY WARRANTY OR REPRESENTATION, EXPRESSED OR",
"IMPLIED, WITH RESPECT TO THE LICENSED MATERIALS, WHICH ARE LICENSED",
"\"AS IS\". ALL OTHER WARRANTIES ARE EXPRESSLY EXCLUDED AND",
"DISCLAIMED, INCLUDING WITHOUT LIMITATION IMPLIED WARRANTIES OF",
"MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, AND ANY WARRANTIES",
"ARISING BY STATUTE OR OTHERWISE IN LAW OR FROM COURSE OF DEALING, COURSE",
"OF PERFORMANCE, OR USE OF TRADE. ANY STATEMENTS OR REPRESENTATIONS MADE",
"BY ANY OTHER PERSON OR ENTITY ARE VOID. YOU ASSUME ALL RISK AS TO THE",
"QUALITY, FUNCTION, PERFORMANCE, AND ACCURACY OF THE LICENSED MATERIALS.",
"   </p>",
"   <p>",
"    LIMITATION OF LIABILITY: IN NO EVENT WILL UPTODATE OR ANY OTHER",
"PARTY WHO HAS BEEN INVOLVED IN THE CREATION, PRODUCTION, PROMOTION OR",
"MARKETING OF THE LICENSED MATERIALS BE LIABLE TO YOU OR ANY OTHER PARTY",
"FOR ANY SPECIAL, INDIRECT, INCIDENTAL, RELIANCE, EXEMPLARY, OR",
"CONSEQUENTIAL DAMAGES, INCLUDING LOSS OF DATA OR PROFITS, OR FOR",
"INABILITY TO USE THE LICENSED MATERIALS, EVEN IF UPTODATE OR SUCH OTHER",
"PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN NO EVENT",
"SHALL UPTODATE OR SUCH OTHER PARTY'S LIABILITY FOR ANY DAMAGES OR LOSS",
"TO YOU OR ANY OTHER PARTY EXCEED THE LICENSE FEE PAID FOR THE LICENSED",
"MATERIALS.",
"   </p>",
"   <p>",
"    Some jurisdictions do not allow limitations on how long an",
"implied warranty lasts and some jurisdictions do not allow the exclusion",
"or limitation of special, indirect, incidental, exemplary, or",
"consequential damages, or the limitation of liability to specified",
"amounts, so the above limitation and exclusion may not apply to you if",
"prohibited by applicable law. You may also have other rights which vary",
"from jurisdiction to jurisdiction. You agree that this Agreement shall",
"not be subject to the United Nations Convention on Contracts for the",
"International Sale of Goods.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"GENERAL: If any provision of this Agreement is determined to be invalid",
"or unenforceable under any applicable law, it shall be deemed omitted",
"and the remaining provisions shall continue in full force and effect.",
"This Agreement may be modified only in writing authorized by UpToDate.",
"UpToDate's waiver of any right shall not constitute a waiver of that or",
"any other right in the future. This Agreement shall be governed by and",
"construed in accordance with the laws and in the state and federal",
"courts of the Commonwealth of Massachusetts, USA. This Agreement",
"constitutes the entire understanding between the parties with respect to",
"the subject matter hereof, and all prior agreements, representations,",
"statements, and undertakings, oral or written, are hereby expressly",
"superseded and canceled. Sections 2 and 4-9 survive in full force and",
"effect following expiration or termination of this Agreement.",
"   </p>",
"   <p>",
"    Should you have any questions regarding this Agreement, you may",
"contact UpToDate at the email address or telephone numbers set forth",
"below.",
"   </p>",
"   <p>",
"    UpToDate, Inc.",
"    <br/>",
"    <a href=\"#\" id=\"infoEmail\">",
"     info@uptodate.com",
"    </a>",
"    <br/>",
"    Telephone: 1-800-998-6374 or +1-781-392-2000",
"   </p>",
"  </div>",
"  <div id=\"slaButtons\">",
"   <input id=\"closeSLABtn\" type=\"button\" value=\"Close\"/>",
"  </div>",
" </div>",
" <div id=\"slaMask\">",
" </div>",
" <script type=\"text/javascript\">",
"  $(function(){		",
"				$.extend($$.showSLAMessage,{",
"					checkUrl: '/services/AgreementWebService?type=sla_msg_check',",
"					acceptDrugUrl: '/services/AgreementWebService?type=drug'",
"				});",
"				$$.showSLAMessage.init();",
"			});",
" </script>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"headerLogo\">",
"    <a href=\"./search\">",
"     <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"     </img>",
"    </a>",
"   </div>",
"   <div id=\"headerLinks\">",
"    <a href=\"/home/about-us\" target=\"_blank\">",
"     About Us",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"file://learn.uptodate.com/global\" id=\"newsLink\" target=\"_blank\">",
"     News from UpToDate",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"/home/contact-us\" target=\"_blank\">",
"     Contact Us",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"/help\">",
"     Help",
"    </a>",
"   </div>",
"   <div id=\"headerFeedback\">",
"    <img alt=\"white circle\" src=\"./../images/icn_feedback_arw.myextg\">",
"     <a href=\"/login\" id=\"headerLogin\">",
"      Log in",
"     </a>",
"    </img>",
"   </div>",
"   <div id=\"headerMenu\">",
"    <ul>",
"     <li>",
"      <img alt=\"\" class=\"menuUp\" height=\"23\" src=\"./../images/menu_up.myextg\" width=\"14\"/>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"searchTab\">",
"      <a href=\"./search\">",
"       New Search",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"patientInfoTab\">",
"      <a href=\"UTD.htm?18/22/18798\">",
"       Patient Info",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"whatsNewTab\" }>",
"      <a href=\"UTD.htm?3/13/3294\">",
"       What's New",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"calcTab\">",
"      <a href=\"UTD.htm?0/37/606\">",
"       Calculators",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li style=\"background-image: url(/images/spacer.myextg);\">",
"      <img alt=\"\" height=\"23\" src=\"./../images/right_shim.myextg\" width=\"16\"/>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"topSearchBar\">",
"    <form action=\"./search.do\" method=\"get\" name=\"SearchForm\">",
"     <div id=\"smallSearchBox\">",
"      <div id=\"new_search\">",
"       <div id=\"searchbox_dd\">",
"        <input autocomplete=\"off\" id=\"txtSearch\" maxlength=\"200\" name=\"search\" type=\"text\" value=\"\"/>",
"        <span id=\"searchbox_dd_submit\">",
"         Search",
"        </span>",
"        <span id=\"searchbox_dd_type\" title=\"Change Search Type\">",
"         <span id=\"searchbox_dd_type_name\">",
"         </span>",
"        </span>",
"       </div>",
"       <div id=\"searchbox_dd_dropdown\">",
"        <ul id=\"searchbox_dd_dropdown_topics\">",
"         <li class=\"active\" id=\"searchoption_topic_all\">",
"          All Topics",
"         </li>",
"         <li id=\"searchoption_topic_adult\">",
"          Adult",
"         </li>",
"         <li id=\"searchoption_topic_pediatric\">",
"          Pediatric",
"         </li>",
"         <li id=\"searchoption_topic_patient\">",
"          Patient",
"         </li>",
"        </ul>",
"        <ul id=\"searchbox_dd_dropdown_graphics\">",
"         <li id=\"searchoption_graphics\">",
"          Graphics",
"         </li>",
"        </ul>",
"       </div>",
"       <input id=\"spinput\" name=\"sp\" type=\"hidden\" value=\"0\"/>",
"       <!-- the real searchType input, value is copied from above radio buttons with jquery",
"		because the radio buttons are moved outside of the form (for display purposes) -->",
"       <input id=\"searchType\" name=\"searchType\" type=\"hidden\" value=\"0\"/>",
"       <input id=\"source\" name=\"source\" type=\"hidden\" value=\"USER_INPUT\">",
"        <input id=\"searchControl\" name=\"searchControl\" type=\"hidden\" value=\"TOP_PULLDOWN\">",
"         <input name=\"searchOffset\" type=\"hidden\" value=\"\">",
"         </input>",
"        </input>",
"       </input>",
"      </div>",
"     </div>",
"    </form>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      Nitroglycerin (glyceryl trinitrate): Patient drug information",
"     </span>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <!-- <a href=\"#\" onclick=\"javascript:$('body').removeClass('fontSmall fontMed fontLarge').addClass('fontSmall');return false;\" id=\"fontSmall\" class=\"fontControl\" title=\"Smaller Font\"></a><a href=\"#\" onclick=\"javascript:$('body').removeClass('fontSmall fontMed fontLarge').addClass('fontMed');return false;\" id=\"fontMed\" class=\"fontControl\" title=\"Normal Font\"></a><a href=\"#\" onclick=\"javascript:$('body').removeClass('fontSmall fontMed fontLarge').addClass('fontLarge');return false;\" id=\"fontLarge\" class=\"fontControl\" title=\"Larger Font\"></a>-->",
"     <a class=\"findInPageLink\" href=\"#\">",
"      <img alt=\"Find in Topic\" src=\"./../images/icn_fop.myextg\" title=\"Find in Topic\"/>",
"     </a>",
"     <a class=\"findInPageLink icontxt textLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a href=\"UTD.htm?9/10/9382?topicKey=DRUG_PTI%2F10913&amp;elapsedTimeMs=3&amp;view=print&amp;displayedView=full\">",
"      <img alt=\"Print This Topic\" src=\"./../images/icn_print.myextg\" title=\"Print This Topic\"/>",
"     </a>",
"     <a class=\"icontxt textLink\" href=\"UTD.htm?9/10/9382?topicKey=DRUG_PTI%2F10913&amp;elapsedTimeMs=3&amp;view=print&amp;displayedView=full\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"    </div>",
"   </div>",
"   <div id=\"findInPage\" title=\"Find in Topic\">",
"    <div id=\"findInPageInput\" style=\"display: none;\">",
"     <input id=\"findInPageTerm\" maxlength=\"30\" size=\"30\" type=\"text\">",
"      <p>",
"       <input checked=\"checked\" name=\"findInPageSearchType\" type=\"radio\" value=\"syn\">",
"        <span class=\"icontxt\">",
"         Find synonyms",
"        </span>",
"        <input name=\"findInPageSearchType\" type=\"radio\" value=\"exact\">",
"         <span class=\"icontxt\">",
"          Find exact match",
"         </span>",
"        </input>",
"       </input>",
"      </p>",
"      <div id=\"findInPageButtons\">",
"       <input class=\"icontxt\" id=\"findInPageFind\" type=\"button\" value=\"Find\">",
"        <input class=\"icontxt\" id=\"findInPageClear\" type=\"button\" value=\"Clear\">",
"        </input>",
"       </input>",
"      </div>",
"     </input>",
"    </div>",
"    <div id=\"findInPageProgress\" style=\"display: none;\">",
"     <img src=\"./../images/progress.myextg\">",
"      Searching for",
"      <span class=\"emphasis\" id=\"findInPageProgressTerm\">",
"      </span>",
"     </img>",
"    </div>",
"    <div id=\"findInPageResults\" style=\"display: none;\">",
"     We found",
"     <span class=\"emphasis findInPageResultsCount\">",
"     </span>",
"     &nbsp;",
"     <span class=\"emphasis\" id=\"findInPageResultsInstance\">",
"     </span>",
"     &nbsp;of&nbsp;",
"     <span class=\"emphasis\" id=\"findInPageResultsTerm\">",
"     </span>",
"     <div id=\"findInPageResultsIterator\" style=\"display: none;\">",
"      <span class=\"emphasis\" id=\"findInPageResultsIndex\">",
"       1",
"      </span>",
"      &nbsp;of&nbsp;",
"      <span class=\"findInPageResultsCount\">",
"      </span>",
"      &nbsp;highlighted",
"      <input class=\"icontxt\" id=\"findInPageResultsNext\" type=\"button\" value=\"Next\">",
"       <input class=\"icontxt\" id=\"findInPageResultsClear\" type=\"button\" value=\"Clear\">",
"       </input>",
"      </input>",
"     </div>",
"     <div id=\"findInPageResultsNone\" style=\"display: none;\">",
"      <input class=\"icontxt\" id=\"findInPageResultsNewFind\" type=\"button\" value=\"New Find\">",
"      </input>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"     <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"      <br>",
"       <div id=\"printHeaderText\">",
"        Official reprint from  UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"        <br>",
"         <a href=\"file://www.uptodate.com\">",
"          www.uptodate.com",
"         </a>",
"         &copy;2013 UpToDate",
"         <sup>",
"          &reg;",
"         </sup>",
"        </br>",
"       </div>",
"      </br>",
"     </img>",
"    </img>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <!-- TC:TOPIC_PAGE -->",
"  <div id=\"topicContent\">",
"   <div id=\"disclaimer\">",
"    The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"    <a href=\"/home/terms-use\" target=\"_blank\">",
"     UpToDate Terms of Use",
"    </a>",
"    &copy;2013 UpToDate, Inc.",
"   </div>",
"   <div id=\"drugTitle\">",
"    Nitroglycerin (glyceryl trinitrate): Patient drug information",
"   </div>",
"   <div id=\"lexiTitleImg\">",
"    <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"   </div>",
"   <div class=\"clear\">",
"   </div>",
"   <div id=\"drugCopy\">",
"    Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"   </div>",
"   <div id=\"topicText\">",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"      see \"Nitroglycerin (glyceryl trinitrate): Drug information\"",
"     </a>",
"     and",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/7/34934?source=see_link\">",
"      see \"Nitroglycerin (glyceryl trinitrate): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F202098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      Brand Names: U.S.",
"     </span>",
"     <ul>",
"      <li>",
"       Minitran&trade;;",
"      </li>",
"      <li>",
"       Nitro-Bid&reg;;",
"      </li>",
"      <li>",
"       Nitro-Dur&reg;;",
"      </li>",
"      <li>",
"       Nitro-Time&reg;;",
"      </li>",
"      <li>",
"       Nitrolingual&reg;;",
"      </li>",
"      <li>",
"       NitroMist&reg;;",
"      </li>",
"      <li>",
"       Nitrostat&reg;;",
"      </li>",
"      <li>",
"       Rectiv&reg;",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F202099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      Brand Names: Canada",
"     </span>",
"     <ul>",
"      <li>",
"       Minitran&trade;;",
"      </li>",
"      <li>",
"       Mylan-Nitro Sublingual Spray;",
"      </li>",
"      <li>",
"       Nitro-Dur&reg;;",
"      </li>",
"      <li>",
"       Nitroglycerin Injection, USP;",
"      </li>",
"      <li>",
"       Nitrol&reg;;",
"      </li>",
"      <li>",
"       Nitrostat&reg;;",
"      </li>",
"      <li>",
"       Rho&reg;-Nitro Pump Spray;",
"      </li>",
"      <li>",
"       Transderm-Nitro&reg;;",
"      </li>",
"      <li>",
"       Trinipatch&reg;",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      Warning",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2700602",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      What is this drug used for?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2691499",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        It is used to stop or treat chest pain or pressure.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2691384",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        It is used to help a weak heart.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s3521619",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        It is used to treat anal pain.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      What do I need to tell my doctor before I take this drug?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2702612",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If you have an allergy to nitroglycerin or any other part of this drug.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2701445",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If you have an allergy to adhesive.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2705171",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2980839",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If you have any of these health problems: Anemia, bleeding in the brain, or head injury.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      What are some things I need to know or do while I take this drug?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2697780",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Wear disease medical alert ID (identification).",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2697650",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        The patch may have metal. Take off the patch before an MRI.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698416",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Have your blood pressure and heart rate checked often. Talk with your doctor.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696717",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699677",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696618",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Avoid beer, wine, or mixed drinks.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2697641",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2697636",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022482\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      What are some side effects of this drug?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698051",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698094",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Flushing. Wearing layers of clothes or summer clothes and staying in cool places may help.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698124",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Headache. Most of the time it gets better after taking this drug for a week.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698344",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Skin irritation.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698721",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699066",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698621",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Chest pain or pressure lasting more than 15 minutes.",
"        <b>",
"         Get emergency medical care right away.",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698961",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Raised rate, time it lasts, or harshness of chest pain.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699023",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Very bad dizziness or passing out.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698640",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Trouble breathing.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699031",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Very bad headache.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698603",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Any rash.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2698977",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Side effect or health problem is not better or you are feeling worse.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      How is this drug best taken?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705559",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Sublingual (under the tongue):",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695645",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Sit down before use.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695688",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Sublingual tablet: Place under your tongue and let melt.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696231",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Wait 5 minutes. If chest pain or pressure is still present, call the ER (emergency department) or get a ride to the hospital. Do not drive yourself.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705558",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Spray:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695663",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Spray on or under tongue.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2694553",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Avoid swallowing after use.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2694551",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Avoid rinsing mouth for 5 to 10 minutes after use.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696231",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Wait 5 minutes. If chest pain or pressure is still present, call the ER (emergency department) or get a ride to the hospital. Do not drive yourself.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705592",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Nitrolingual&reg;:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695546",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Prime pump by spraying it 5 times.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695131",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If not used in 6 weeks prime pump by spraying it 1 time.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705593",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          NitroMist&trade;:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695544",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Prime pump by spraying it 10 times.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695132",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If not used in 6 weeks prime pump by spraying it 2 times.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705490",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Oral:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695780",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Take oral products on an empty stomach. Take 1 hour before meals or 2 hours after meals.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695322",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Long-acting products: Swallow whole. Do not chew, break, or crush.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695899",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Take with a full glass of water.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705548",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Skin: Ointment (topical):",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696257",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Wash your hands before and after use.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696205",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Use the applicator or dose-measuring paper to spread in a thin layer over a 2x3 inch part. Put on your chest or back.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705519",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Rectal:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s3521621",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Cover your finger with plastic-wrap, a surgical glove, or a finger cot.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s3521623",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Use the dosing guide on the box to put the ointment on your covered finger.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s3521624",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Place the finger with the ointment on it into the anal canal up to the first finger joint.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s3521625",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Smear the ointment inside the anus.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s3521626",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        You may also put the ointment on the outside of your anus.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696254",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Wash your hands after use.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705500",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Patch:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2694870",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Follow how to use as you have been told by your doctor or read the package insert.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2694470",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Put patch on at the same time of day.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2694474",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Put patch on a site without hair.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705429",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Shot:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2695989",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        It is given as a shot into a vein over a period of time.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      What do I do if I miss a dose?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696563",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Take a missed dose as soon as you think about it.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696496",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696475",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Do not take 2 doses at the same time or extra doses.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2696540",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Many times this drug is taken on an as needed basis.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      How do I store and/or throw out this drug?",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705490",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Oral:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699336",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Store at room temperature.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699264",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Protect from light.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699266",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Store in a dry place. Do not store in a bathroom.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699659",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Store sublingual tablets in the original container at room temperature. Keep the cap tightly closed. Throw away any part not used when the date on the bottle has been reached.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"link\">",
"         urn:lims:b498:s2705429",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        <b>",
"         <span style=\"text-decoration: underline\">",
"          Shot:",
"         </span>",
"        </b>",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b498:s2699585",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"     <span class=\"drugH1\">",
"      General drug facts",
"     </span>",
"     <ul class=\"statements\" style=\"list-style-type:none;\">",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s2699675",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s2699673",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Do not share your drugs with others and do not take anyone else's drugs.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s2699678",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Keep all drugs out of the reach of children and pets.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s2699709",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s3302581",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s2699677",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s2699671",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"       </span>",
"      </li>",
"      <li class=\"statement\">",
"       <span class=\"attributes\" style=\"display:none;\">",
"        <span class=\"entity\">",
"         &bull;",
"        </span>",
"        <span class=\"link\">",
"         urn:lims:b259:s2699683",
"        </span>",
"       </span>",
"       <span class=\"content\">",
"        Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"       </span>",
"      </li>",
"     </ul>",
"    </div>",
"   </div>",
"   <div id=\"topicAgreement\">",
"    Use of UpToDate is subject to the",
"    <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"     Subscription and License Agreement",
"    </a>",
"    .",
"   </div>",
"   <div id=\"topicVersionRevision\">",
"    Topic 10913 Version 40.0",
"   </div>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"     Subscription and License Agreement",
"    </a>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.6- C21.56",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      AsanBook Dig. Med. Lib.",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [1104-113.53.254.124-576A95D1BF-S244013.14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
" <div id=\"leftPanel\">",
" </div>"].join("\n");
var script_f9_10_9382=[""].join("\n");
var outline_f9_10_9382=null;
var title_f9_10_9383="Invasive mucinous adenocarcinoma";
var content_f9_10_9383=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Invasive mucinous adenocarcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 203px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) This area of invasive mucinous adenocarcinoma demonstrates a pure lepidic growth. The tumor consists of columnar cells filled with abundant mucin in the apical cytoplasm and shows small basal oriented nuclei.",
"    <br>",
"     (B) Nevertheless, elsewhere this tumor demonstrated invasion associated with desmoplastic stroma and an acinar pattern.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6:244. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9383=[""].join("\n");
var outline_f9_10_9383=null;
var title_f9_10_9384="Acute hemorrhagic erosive gastropathy and chronic chemical gastropathy";
var content_f9_10_9384=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute hemorrhagic erosive gastropathy and chronic chemical gastropathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9384/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9384/contributors\">",
"     Pamela J Jensen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9384/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9384/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9384/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9384/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9384/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/10/9384/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury to the gastric mucosa is associated with epithelial cell damage and regeneration. The term gastritis is used to denote inflammation associated with mucosal injury.",
"   </p>",
"   <p>",
"    Epithelial cell damage and regeneration without associated inflammation is properly referred to as \"gastropathy\" [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31205?source=see_link\">",
"     \"Classification and diagnosis of gastritis and gastropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The causes, natural history, and therapeutic implications of gastropathy differ from gastritis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastropathy is usually caused by irritants such as drugs (eg, nonsteroidal antiinflammatory agents and alcohol), bile reflux, hypovolemia, and chronic congestion.",
"     </li>",
"     <li>",
"      Gastritis is usually due to infectious agents (such as Helicobacter pylori) and autoimmune and hypersensitivity reactions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most classification systems distinguish acute, short-term from chronic, long-term disease. The terms acute and chronic are also used to describe the type of inflammatory cell infiltrate. Acute inflammation is usually associated with neutrophilic infiltration, while chronic inflammation is usually characterized by mononuclear cells, chiefly lymphocytes, plasma cells, and macrophages. A practical clinicopathologic framework for the classification of gastritis and gastropathy based upon these factors can be proposed (",
"    <a class=\"graphic graphic_table graphicRef73286 \" href=\"UTD.htm?38/54/39788\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss acute hemorrhagic and erosive gastropathy and chronic chemical gastropathy. The classification and diagnosis of gastritis and gastropathy, and the causes of acute and chronic gastritis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31205?source=see_link\">",
"     \"Classification and diagnosis of gastritis and gastropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30055?source=see_link\">",
"     \"Acute and chronic gastritis due to Helicobacter pylori\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACUTE HEMORRHAGIC AND EROSIVE GASTROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hallmark of acute hemorrhagic and erosive gastropathy is the development of hemorrhagic and erosive lesions shortly after exposure of the gastric mucosa to various injurious substances or a substantial reduction in mucosal blood flow. The gastropathy is caused by damage to the surface epithelium, which may be due to a direct action of injurious agents (such as nonsteroidal antiinflammatory drugs [NSAIDs], alcohol, or bile acids) or to mucosal hypoxia (such as in trauma, burns [Curling's ulcers] or sepsis) or to a combination of factors such as with antineoplastic chemotherapy. Gastric and duodenal ulceroinflammatory lesions occurring during severe damage to the central nervous system (Cushing's ulcers) are often considered in this group, although some authorities consider them to be clinically and pathogenetically distinct [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18776?source=see_link\">",
"     \"Stress ulcer prophylaxis in the intensive care unit\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As a result of the acute mucosal injury, the normal protective barrier (which includes secreted mucins, bicarbonate, and the epithelium itself) is disrupted. This permits acid and other luminal substances (eg. proteases and bile acids) to penetrate into the lamina propria, where they cause additional injury to the vasculature, stimulate nerves, and cause the release of histamine and other inflammatory mediators [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The mucosal injury increases significantly during the reperfusion that follows ischemia due to the production of toxic oxygen-free radicals by infiltrating neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An additional specific pathogenetic factor in NSAID-induced acute hemorrhagic and erosive gastropathy is the inhibition of prostaglandin production. Prostaglandins, especially those of the E class, protect against acute mucosal injury due to NSAIDs and other injurious substances by several mechanisms, including the stimulation of mucus and bicarbonate secretion, and maintenance of mucosal blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6745?source=see_link\">",
"     \"NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute gastropathy often presents as abdominal discomfort, pain, heartburn, nausea, vomiting, and hematemesis. Bleeding may be seen three to seven days following the stressful event and can range from occult blood to massive hemorrhage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute hemorrhagic and erosive gastropathy appears as multiple petechial hemorrhages and small red or black erosions on endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Stress-related lesions (Curling's ulcers) usually appear in the fundus near the gastroesophageal junction and spread distally, but remain confined to the fundus and body [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/10\">",
"     10",
"    </a>",
"    ]. In contrast, gastropathy due to NSAIDs and alcohol involves the entire stomach from the start, although it may be most evident in the antrum [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/10\">",
"     10",
"    </a>",
"    ]. The erosions in NSAID and alcohol-induced hemorrhagic gastropathy are usually smaller and more rapidly reversible than those seen in hypovolemic gastropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histologically, erosions may have only subtle features because mucosal repair is rapid. In many cases, thin, regenerative epithelium provides the only evidence for their occurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/4\">",
"     4",
"    </a>",
"    ]. Inflammation is usually slight (consisting of no more than a few neutrophils) or absent. Mucosal changes range from hyperemia to massive mucosal necrosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Ulceration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemorrhagic or erosive gastropathy may be associated with the development of gastric or duodenal ulcers. Acute ulceration is most likely to occur in relation to shock-induced hemodynamic instability (ie, the stress ulcer syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12664?source=see_link\">",
"     \"Major causes of upper gastrointestinal bleeding in adults\"",
"    </a>",
"    .) Ulcers are usually multiple, shallow, measure 0.5 to 2.0 cm in diameter, and they are almost exclusively located in the corpus and fundus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/3,4,10,11\">",
"     3,4,10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathologic appearance of the ulcers depends upon their age. Ulcers initially appear necrotic, while older ulcers often demonstrate inflammation, granulation tissue, and epithelial cell regeneration. Ulcers of various ages can usually be found in the same patient [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastric or duodenal ulcers developing in the setting of hemorrhagic gastropathy may be associated with significant bleeding if they extend below the muscularis mucosae into deeper layers where large vessels are located [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/3,4,11\">",
"     3,4,11",
"    </a>",
"    ]. Bleeding is more common from gastric than duodenal ulcers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Common causative agents",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alcohol &ndash; The extent of injury results from the quantity of alcohol ingested and mucosal contact time. Injury usually requires gastric alcohol concentration of &gt;10 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      NSAIDs &ndash; Damage can include acute hemorrhagic gastropathy, erosions, chemical gastropathy, ulcers, and perforation.",
"     </li>",
"     <li>",
"      Cancer chemotherapy &ndash; Damage to gastric mucosa is multifactorial and includes direct mucosa injury, vomiting-induced injury, and immunosuppression (with increased gastric infections). Hepatic arterial infusion chemotherapy can produce alarming regenerative cellular atypia easily confused with carcinoma [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Iron pills &ndash; The consumption of large amounts of oral iron may lead to mucosal necrosis, erosions, and ulcers. Brown pigment may be seen overlying the damaged epithelium [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cocaine &ndash; Injury is caused by intense vasoconstriction with subsequent ischemia due to activation of alpha-adrenergic receptors in the mesentery [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Treatment and prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment and prevention of acute hemorrhagic erosive gastropathy depends upon the cause. The offending agent should be discontinued whenever possible. Antisecretory therapy is also often used to limit concomitant damage from acid exposure.",
"   </p>",
"   <p>",
"    A variety of measures may also be effective for prevention of hemorrhagic gastropathy in high-risk patients. Examples include antisecretory to prevent stress ulceration in the intensive care unit (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18776?source=see_link\">",
"     \"Stress ulcer prophylaxis in the intensive care unit\"",
"    </a>",
"    ), and for those undergoing chemotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CHRONIC CHEMICAL GASTROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term exposure to substances capable of injuring the gastric mucosa can lead to chronic chemical gastropathy. This disorder is characterized by a paucity of inflammation, variable degrees of foveolar hyperplasia, edema, proliferation of smooth muscle fibers in the lamina propria, and vascular dilatation and congestion. These changes were first recognized in severe bile reflux [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/16\">",
"     16",
"    </a>",
"    ], and have subsequently been observed in biopsy specimens from patients with recurrent nonsteroidal anti-inflammatory drug (NSAID)-related mucosal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/17\">",
"     17",
"    </a>",
"    ]. A number of other substances, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    , which can cause acute gastropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/18\">",
"     18",
"    </a>",
"    ], are now suspected causes of chronic chemical gastropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of chronic chemical gastropathy is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of upper abdominal symptoms. Although there are no endoscopic findings that are diagnostic, mucosal changes are usually confined to the antrum or enterogastrostomy sites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A key histologic feature in chronic chemical gastropathy is the paucity of inflammation, which is in sharp contrast to H. pylori gastritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30055?source=see_link\">",
"     \"Acute and chronic gastritis due to Helicobacter pylori\"",
"    </a>",
"    .) In addition, a constellation of findings may be evident, including foveolar hyperplasia, edema, increased smooth muscle fibers in the lamina propria, and vascular dilatation and congestion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Foveolar hyperplasia is characterized by lengthening of the foveolae, with individual cells having reduced height and intracellular mucin depletion. The glands may take on a tortuous, corkscrew appearance in severe cases, as is commonly seen in biopsy specimens taken near gastroenterostomy stomas (in which chemical gastropathy is usually due to bile reflux). Foveolar hyperplasia is part of a spectrum of hyperplastic changes that are found near gastroenterostomy stomas; others include discrete polypoid lesions (ie, polypoid hypertrophic gastritis or gastritis cystica polyposa) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/19\">",
"     19",
"    </a>",
"    ]. Foveolar hyperplasia can regress after bile is diverted from the gastroenterostomy site [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chronic NSAID-associated chemical gastropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenetic connection between acute hemorrhagic and erosive gastropathy and chronic chemical gastropathy associated with NSAIDs is not well-understood. Continued, regular administration of NSAIDs in humans and experimental animals can lead to a reduction in visible hemorrhages and erosions as a result of mucosal adaptation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/21-25\">",
"     21-25",
"    </a>",
"    ]. However, many patients who take these drugs for prolonged periods continue to have ulceroinflammatory lesions with mucosal hemorrhages and erosions or, in approximately 15 percent of patients, gastric or duodenal ulceration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. This outcome has been referred to as \"failed adaptation\" [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6745?source=see_link\">",
"     \"NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The chronic, poorly healing erosions and ulcers that often accompany NSAID-induced chemical gastropathy are usually associated with suppressed epithelial cell regeneration, which can be detected in biopsies obtained from the edge of ulcers [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. The presence of scarring in the muscularis mucosae and submucosa in gastric resection specimens from NSAID users is also consistent with repeated episodes of erosion, ulceration, and repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Bile reflux chemical gastropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bile reflux gastropathy typically results from the regurgitation of bile into the stomach because of an operative stoma, an incompetent pyloric sphincter, or abnormal duodenal motility [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/31\">",
"     31",
"    </a>",
"    ]. The degree of injury reflects the amount of exposure to bile salts. Patients who have a gastroenterostomy, for example, demonstrate the greatest degree of foveolar hyperplasia near the stoma, with decreasing inflammation proximally [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/16,19,32\">",
"     16,19,32",
"    </a>",
"    ]. Bile salt concentration in gastric juice correlates with the severity of hyperplasia in these patients.",
"   </p>",
"   <p>",
"    The effect of bile salts on gastric mucosa is comparable to that seen after chronic NSAID use [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/31\">",
"     31",
"    </a>",
"    ]. Bile salts also appear to be a risk factor for the development of antral metaplastic gastritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/33\">",
"     33",
"    </a>",
"    ]. Animal studies have demonstrated that bile salts and lysolecithin (derived from the metabolism of lecithin) cause acute gastric mucosal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Their degree of toxicity is influenced by a number of variables including the type of bile salt, the presence or absence of deconjugation by bacteria in the intestine or stomach, the gastric pH, and the presence of pancreatic enzymes. Pancreatic enzymes in particular enhance injury from bile salts, in part because they catalyze the formation of lysolecithin from lecithin.",
"   </p>",
"   <p>",
"    Lysolecithin and bile salts break down the gastric mucosal barrier [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/36\">",
"     36",
"    </a>",
"    ], leading to back-diffusion of hydrogen ions and mucosal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Concomitant infection by H. pylori can cause increased inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Cytoprotection from bile-induced injury by prostaglandins has been demonstrated in animal studies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms in patients with bile acid reflux are variable, ranging from histologic changes only without symptoms to abdominal pain, bilious vomiting and weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/40\">",
"     40",
"    </a>",
"    ]. The diagnosis of bile reflux gastropathy is easiest in patients who have surgically altered anatomy predisposing to bile reflux. The demonstration of chronic gastropathy in the absence of other causes is usually sufficient. In contrast, gastropathy in patients with nonoperated stomachs should not be attributed to exposure to bile without evidence of duodenogastric reflux. Duodenogastric reflux can be demonstrated by visualization during endoscopy, bile salt analysis in gastric juice, or radionuclide scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/31,38,41,42\">",
"     31,38,41,42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive treatment of symptomatic bile acid reflux is surgery (usually a Roux-en-Y revision), which has been associated with improvement in symptoms in 50 to 90 percent of patients in several reports [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/40,43-45\">",
"     40,43-45",
"    </a>",
"    ]. Improvement is less likely in patients with delayed gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of medical treatments have been evaluated in small clinical trials with variable success:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"       Ursodeoxycholic acid",
"      </a>",
"      significantly decreased pain and almost abolished nausea and vomiting, but did not improve histology in a placebo controlled crossover trial involving 12 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/46\">",
"       46",
"      </a>",
"      ]. The rationale for its use was based upon the hypothesis that changing the composition of bile acids could have a favorable effect on gastric mucosa and symptoms.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"       Sucralfate",
"      </a>",
"      improved histologic features but not symptoms in a controlled trial involving 23 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prostaglandin E2 was ineffective in improving endoscopic features or symptoms in a double-blind crossover trial [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       Cholestyramine",
"      </a>",
"      combined with alginates (to improve contact time in the gastric remnant) was ineffective on symptoms or histology in a placebo controlled trial that included 32 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Alcohol and other possible causes of chemical gastropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is often difficult to establish with certainty that a particular agent, such as alcohol (ethanol) has caused gastropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/21,50\">",
"     21,50",
"    </a>",
"    ]. Exposure of the gastric mucosa to alcohol is associated with acute hemorrhagic and erosive gastropathy in experimental animals and humans, and chronic alcoholism correlates with presence of hemorrhagic and erosive lesions, [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. However, the available evidence does",
"    <strong>",
"     not",
"    </strong>",
"    convincingly support the conclusion that alcoholic beverages cause chronic chemical gastropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/54-56\">",
"     54-56",
"    </a>",
"    ]. Investigations directed at correlating alcohol consumption and chronic gastropathy are difficult to conduct because of numerous confounding variables, including the presence of other potential causes of gastric injury such as smoking, NSAID use, and H. pylori infection. The types of alcoholic beverages consumed also may be important, primarily because of variations in alcohol concentration and content [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although some investigators have described a correlation between alcohol consumption and chronic gastritis, most such studies antedated the awareness of H. pylori gastritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/58\">",
"     58",
"    </a>",
"    ]. The text and photomicrographs in these articles strongly suggest that the chronic gastritis seen was due to H. pylori. Supporting this hypothesis is one investigation in which chronic gastritis was not found in the absence of H. pylori infection in a small group of alcoholics [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30055?source=see_link\">",
"     \"Acute and chronic gastritis due to Helicobacter pylori\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other agents known to be injurious to gastric mucosa and likely causing chemical gastropathy include potassium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/59\">",
"     59",
"    </a>",
"    ] and iron [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Although smoking has been cited as a risk factor in ulcer disease, there is little or no evidence that it causes chronic gastropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9384/abstract/17,21\">",
"     17,21",
"    </a>",
"    ]. The possible role of persistent hyperacidity in chemical gastropathy remains to be clarified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epithelial cell damage and regeneration without associated inflammation is defined as \"gastropathy\". (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H185154678\">",
"    <span class=\"h2\">",
"     Acute hemorrhagic and erosive gastropathy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The hallmark of acute hemorrhagic and erosive gastropathy is the development of hemorrhagic and erosive lesions shortly after exposure of the gastric mucosa to various injurious substances or a substantial reduction in mucosal blood flow. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Acute hemorrhagic and erosive gastropathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastropathy is usually caused by irritants such as drugs (eg, nonsteroidal antiinflammatory drugs [NSAIDs] and alcohol), bile reflux, hypovolemia, and chronic congestion. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Common causative agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute hemorrhagic and erosive gastropathy appears as multiple petechial hemorrhages and small red or black erosions on endoscopy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute gastropathy often presents as abdominal discomfort, pain, heartburn, nausea, vomiting, and hematemesis. Bleeding may be seen three to seven days following the stressful event and can range from occult blood to massive hemorrhage. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The offending agent should be eliminated in patients with acute hemorrhagic or erosive gastropathy. Preventive measures should be considered in patients at risk while patients with gastrointestinal bleeding should be treated with a proton pump inhibitor. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment and prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13127018\">",
"    <span class=\"h2\">",
"     Chronic chemical gastropathy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Long-term exposure to substances capable of injuring the gastric mucosa can lead to chronic chemical gastropathy. Causes of chronic chemical gastropathy include NSAIDs, bile reflux, and alcohol. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Chronic NSAID-associated chemical gastropathy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Bile reflux chemical gastropathy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Alcohol and other possible causes of chemical gastropathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of chronic chemical gastropathy is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of upper abdominal symptoms. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic chemical gastropathy is characterized by a paucity of inflammation, variable degrees of foveolar hyperplasia, edema, proliferation of smooth muscle fibers in the lamina propria, and vascular dilatation and congestion. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Histopathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The offending agent should be eliminated in patients with chronic chemical gastropathy. No specific treatment has proven to be beneficial in otherwise asymptomatic patients.",
"      <br/>",
"      <br/>",
"      In patients with bile acid reflux, surgery is the definitive treatment. Medical treatments for bile acid reflux have been evaluated in small clinical trials with variable success. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/1\">",
"      Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/2\">",
"      Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995; 108:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/3\">",
"      Marrone GC, Silen W. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions. Clin Gastroenterol 1984; 13:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/4\">",
"      Silen W. The clinical problem of stress ulcers. Clin Invest Med 1987; 10:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/5\">",
"      Davenport HW. Salicylate damage to the gastric mucosal barrier. N Engl J Med 1967; 276:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/6\">",
"      Oates PJ, Hakkinen JP. Studies on the mechanism of ethanol-induced gastric damage in rats. Gastroenterology 1988; 94:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/7\">",
"      Hernandez LA, Grisham MB, Twohig B, et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253:H699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/8\">",
"      Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979; 77:433.",
"     </a>",
"    </li>",
"    <li>",
"     Sloan JM. Acute haemorrhage gastritis and acute infective gastritis, gastritis caused by physical agents and corrosives, uraemic gastritis. In: Gastrointestinal and Oesophageal Pathology, Whitehead R (Ed), Churchill Livingstone, Edinburgh 1989. p.385.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/10\">",
"      Sugawa C, Lucas CE, Rosenberg BF, et al. Differential topography of acute erosive gastritis due to trauma or sepsis, ethanol and aspirin. Gastrointest Endosc 1973; 19:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/11\">",
"      Lev R, Molot MD, McNamara J, Stremple JF. \"Stress\" ulcers following war wounds in Vietnam. A morphologic and histochemical study. Lab Invest 1971; 25:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/12\">",
"      Kvietys PR, Twohig B, Danzell J, Specian RD. Ethanol-induced injury to the rat gastric mucosa. Role of neutrophils and xanthine oxidase-derived radicals. Gastroenterology 1990; 98:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/13\">",
"      Petras RE, Hart WR, Bukowski RM. Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma. Cancer 1985; 56:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/14\">",
"      Haig A, Driman DK. Iron-induced mucosal injury to the upper gastrointestinal tract. Histopathology 2006; 48:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/15\">",
"      Gourgoutis G, Das G. Gastrointestinal manifestations of cocaine addiction. Int J Clin Pharmacol Ther 1994; 32:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/16\">",
"      Dixon MF, O'Connor HJ, Axon AT, et al. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986; 39:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/17\">",
"      Sobala GM, King RF, Axon AT, Dixon MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990; 43:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/18\">",
"      Graham DY, Malaty HM, Goodgame R. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin. Am J Gastroenterol 1997; 92:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/19\">",
"      Koga S, Watanabe H, Enjoji M. Stomal polypoid hypertrophic gastritis: a polypoid gastric lesion at gastroenterostomy site. Cancer 1979; 43:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/20\">",
"      Bechi P, Amorosi A, Mazzanti R, et al. Short-term effects of bile diversion on postgastrectomy gastric histology. Dig Dis Sci 1988; 33:1288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/21\">",
"      Domschke S, Domschke W. Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 1984; 13:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/22\">",
"      Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986; 104:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/23\">",
"      Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. Arch Intern Med 1987; 147:2093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/24\">",
"      Shorrock CJ, Rees WD. Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism. Gut 1992; 33:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/25\">",
"      Konturek SJ, Brzozowski T, Majka J, et al. Adaptation of the gastric mucosa to stress. Role of prostaglandin and epidermal growth factor. Scand J Gastroenterol Suppl 1992; 193:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/26\">",
"      Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/27\">",
"      Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/28\">",
"      Olivero JJ, Graham DY. Gastric adaptation to nonsteroidal anti-inflammatory drugs in man. Scand J Gastroenterol Suppl 1992; 193:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/29\">",
"      Levi S, Goodlad RA, Lee CY, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/30\">",
"      Myszor M, Hodgson HJ. Non-steroidal anti-inflammatory drugs and gastric DNA synthesis. Scand J Gastroenterol 1990; 25:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/31\">",
"      Niemel&auml; S. Duodenogastric reflux in patients with upper abdominal complaints or gastric ulcer with particular reference to reflux-associated gastritis. Scand J Gastroenterol Suppl 1985; 115:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/32\">",
"      Weinstein WM, Buch KL, Elashoff J, et al. The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury. Scand J Gastroenterol Suppl 1985; 109:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/33\">",
"      Nakamura M, Haruma K, Kamada T, et al. Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 2001; 53:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/34\">",
"      Orchard R, Reynolds K, Fox B, et al. Effect of lysolecithin on gastric mucosal structure and potential difference. Gut 1977; 18:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/35\">",
"      Eastwood GL. Effect of pH on bile salt injury to mouse gastric mucosa. A light- and electron-microscopic study. Gastroenterology 1975; 68:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/36\">",
"      Davenport HW. Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 1968; 54:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/37\">",
"      Loffeld RJ, Loffeld BC, Arends JW, et al. Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomy. J Clin Pathol 1988; 41:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/38\">",
"      Karttunen T, Niemel&auml; S. Campylobacter pylori and duodenogastric reflux in peptic ulcer disease and gastritis. Lancet 1988; 1:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/39\">",
"      Dempsey DT, Mercer DW, Deb B, et al. Adaptive cytoprotection of gastric surface epithelial cells against injury by physiologic concentrations of bile acid. Surgery 1990; 108:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/40\">",
"      Bondurant FJ, Maull KI, Nelson HS Jr, Silver SH. Bile reflux gastritis. South Med J 1987; 80:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/41\">",
"      Stein HJ, Smyrk TC, DeMeester TR, et al. Clinical value of endoscopy and histology in the diagnosis of duodenogastric reflux disease. Surgery 1992; 112:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/42\">",
"      Niemel&auml; S, Karttunen T, Heikkil&auml; J, Lehtola J. Characteristics of reflux gastritis. Scand J Gastroenterol 1987; 22:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/43\">",
"      Davidson ED, Hersh T. The surgical treatment of bile reflux gastritis: a study of 59 patients. Ann Surg 1980; 192:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/44\">",
"      Capussotti L, Marucci MM, Arico S, et al. Long-term results of surgical treatment for alkaline reflux gastritis in gastrectomized patients. Am J Gastroenterol 1984; 79:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/45\">",
"      Tass&eacute; D, Ghosn PO, Gagnon M, et al. Alkaline reflux gastritis: Roux-en-Y diversion is effective. Can J Surg 1982; 25:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/46\">",
"      Stefaniwsky AB, Tint GS, Speck J, et al. Ursodeoxycholic acid treatment of bile reflux gastritis. Gastroenterology 1985; 89:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/47\">",
"      Buch KL, Weinstein WM, Hill TA, et al. Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. A randomized, double-blind study. Am J Med 1985; 79:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/48\">",
"      Nicolai JJ, van de Stadt J, Tytgat GN. Double-blind crossover trial of prostaglandin E2 in postgastrectomy reflux gastritis. Dig Dis Sci 1986; 31:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/49\">",
"      Nicolai JJ, Speelman P, Tytgat GN, van der Stadt J. Comparison of the combination of cholestyramine/alginates with placebo in the treatment of postgastrectomy biliary reflux gastritis. Eur J Clin Pharmacol 1981; 21:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/50\">",
"      Kurata JH, Elashoff JD, Grossman MI. Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleeding. Gastroenterology 1982; 82:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/51\">",
"      Laine L, Weinstein WM. Histology of alcoholic hemorrhagic \"gastritis\": a prospective evaluation. Gastroenterology 1988; 94:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/52\">",
"      Segawa K, Nakazawa S, Tsukamoto Y, et al. Endoscopic study of upper gastrointestinal tract in patients with alcohol dependence. Jpn J Med 1987; 26:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/53\">",
"      Bernersen B, Johnsen R, Straume B, Burhol PG. Erosive prepyloric changes in dyspeptics and non-dyspeptics in a defined population. The S&oslash;rreisa Gastrointestinal Disorder Study. Scand J Gastroenterol 1992; 27:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/54\">",
"      Cheli R, Giacosa A, Marenco G, et al. Chronic gastritis and alcohol. Z Gastroenterol 1981; 19:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/55\">",
"      Oddsson E, Binder V, Thorgeirsson T, et al. A prospective comparative study of clinical and pathological characteristics in Icelandic and Danish patients with gastric ulcer, duodenal ulcer, and X-ray negative dyspepsia. II. Histological results. Scand J Gastroenterol 1978; 13:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/56\">",
"      Uppal R, Lateef SK, Korsten MA, et al. Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori. Arch Intern Med 1991; 151:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/57\">",
"      McIntosh JH, Byth K, Piper DW. Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. Gut 1985; 26:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/58\">",
"      Parl FF, Lev R, Thomas E, Pitchumoni CS. Histologic and morphometric study of chronic gastritis in alcoholic patients. Hum Pathol 1979; 10:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/59\">",
"      McMahon FG, Ryan JR, Akdamar K, Ertan A. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial. Lancet 1982; 2:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/60\">",
"      Laine LA, Bentley E, Chandrasoma P. Effect of oral iron therapy on the upper gastrointestinal tract. A prospective evaluation. Dig Dis Sci 1988; 33:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9384/abstract/61\">",
"      Abraham SC, Yardley JH, Wu TT. Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity. Am J Surg Pathol 1999; 23:1241.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 36 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-EF161DC620-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9384=[""].join("\n");
var outline_f9_10_9384=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACUTE HEMORRHAGIC AND EROSIVE GASTROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Ulceration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Common causative agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CHRONIC CHEMICAL GASTROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chronic NSAID-associated chemical gastropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Bile reflux chemical gastropathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Alcohol and other possible causes of chemical gastropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H185154678\">",
"      Acute hemorrhagic and erosive gastropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13127018\">",
"      Chronic chemical gastropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/36\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/36|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/54/39788\" title=\"table 1\">",
"      Classification of gastritis and gastropathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30055?source=related_link\">",
"      Acute and chronic gastritis due to Helicobacter pylori",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31205?source=related_link\">",
"      Classification and diagnosis of gastritis and gastropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12664?source=related_link\">",
"      Major causes of upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6745?source=related_link\">",
"      NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18776?source=related_link\">",
"      Stress ulcer prophylaxis in the intensive care unit",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_10_9385="Lentigo maligna histology";
var content_f9_10_9385=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F60447&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F60447&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lentigo maligna",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Atypical melanocytes grow largely at the dermal-epidermal interface (straight arrow), with extension down the external root sheath of follicles (curved arrow). Upward growth of melanocytes is much less prominent than in intraepidermal malignant melanoma of the superficial spreading type.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin R, Strayer DS. Rubin's Pathology: Clinicopathologic Foundations of Medicine, 5th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9385=[""].join("\n");
var outline_f9_10_9385=null;
var title_f9_10_9386="Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection";
var content_f9_10_9386=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9386/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9386/contributors\">",
"     Mary A Albrecht, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9386/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9386/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/10/9386/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/10/9386/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/10/9386/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genital herpes simplex virus (HSV) infections are a major global public health problem:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A dramatic upsurge in genital HSV infections has been documented from seroprevalence studies.",
"     </li>",
"     <li>",
"      There is a wide diversity of the clinical spectrum of genital HSV disease.",
"     </li>",
"     <li>",
"      Like all herpes virus strains, HSV establishes a latent state followed by viral reactivation and recurrent local disease.",
"     </li>",
"     <li>",
"      Perinatal transmission of HSV can lead to significant fetal morbidity and mortality.",
"     </li>",
"     <li>",
"      A link has been established between HSV-related genital ulcer disease and sexual transmission of HIV.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The epidemiology, varied clinical manifestations, and diagnosis of genital HSV infection will be reviewed here. The treatment of this disorder and issues related to genital herpes in pregnancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/32/7690?source=see_link\">",
"     \"Treatment of genital herpes simplex virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/15/21751?source=see_link\">",
"     \"Prevention of genital herpes virus infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=see_link\">",
"     \"Genital herpes simplex virus infection and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) are common infections worldwide; at least 50 million persons have genital herpes in the United States alone [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In addition, genital HSV is frequently under-recognized because infection is often subclinical [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]; in a population-based cross-sectional survey of adults living in New York City, nearly 28 percent were infected with HSV-2 and 88 percent had no prior knowledge of their diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/5\">",
"     5",
"    </a>",
"    ]. Prior infection with HSV-1 also leads to a three-fold increase in asymptomatic HSV-2 infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a follow-up cross-sectional seroprevalence survey in the United States, trends in HSV-1 and HSV-2 infections in 1999 to 2004 (11,508 participants) were compared to 1988 to 1994 (9165 participants) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/1\">",
"     1",
"    </a>",
"    ]. The survey demonstrated the following results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In participants 14 to 49 years of age, the seroprevalence of HSV-2 declined from 21 percent to 17 percent in the later study period (a relative decrease of 19 percent).",
"     </li>",
"     <li>",
"      The seroprevalence of HSV-1 declined from 62 to 58 percent (a relative decrease of 7 percent).",
"     </li>",
"     <li>",
"      Among persons who were seropositive for only HSV-1, a higher percentage was diagnosed with genital herpes in the later study period.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This report is consistent with other data that suggest that HSV-1 is associated with an increasing proportion of cases of genital herpes infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Over a two-year follow-up of 1427 HIV-seronegative MSM in Australia, incidence rates for HSV-1 and HSV-2 infection were 5.9 and 1.5 cases per 100 person-years, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/9\">",
"       9",
"      </a>",
"      ]. In a multivariate analysis, incident infection with HSV-1 was significantly associated with younger age and reports of insertive oral sex with casual partners.",
"     </li>",
"     <li>",
"      In a retrospective analysis of genital herpes isolates from a university student health service in the United States, HSV-1 was more commonly isolated in women than men, and the proportion of newly diagnosed HSV-1 genital infection had increased from 31 percent in 1993 to 78 percent in 2001 [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among 3438 HSV-seronegative women between the ages of 18 and 30 in the United States and Canada who were enrolled in the control arm of a herpes vaccine study and who were followed prospectively between 2003 and 2007, 183 became infected with HSV: 127 (3.7 percent) with HSV-1 and 56 (1.6 percent) with HSV-2 [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/4\">",
"       4",
"      </a>",
"      ]. The rate of infection for HSV-1 was more than twice the rate for HSV-2 (2.5 versus 1.1 per 100 person-years, respectively). HSV-1 was more common than HSV-2 as a cause of genital mucosal infections.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The rate of newly acquired HSV-2 infections was 5.1 cases per 100 person-years in a prospective study in 2393 HSV-2 antibody-negative, sexually active adults of whom 63 percent were seropositive for HSV-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/6\">",
"     6",
"    </a>",
"    ]. Only 37 percent of the 155 new HSV-2 infections were symptomatic. Thus, it is estimated that the majority of genital herpes infections are transmitted by persons unaware that they have the infection, or are asymptomatic when transmission occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/2\">",
"     2",
"    </a>",
"    ]. Prior HSV-1 infection did not affect the rate of HSV-2 acquisition, but did increase the likelihood of asymptomatic infection by three-fold. Superinfection of the same anatomic site by both HSV-1 and HSV-2 has also been documented [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These seroepidemiologic studies have also served to identify important risk factors for the acquisition of HSV-2. In a survey conducted by the United States Centers for Disease Control and Prevention, among persons aged 14 to 49 years of age in the United States, overall HSV-2 seroprevalence remained stable at 16 percent; seroprevalence increased with age, numbers of sexual partners, and was greater among women (21 percent) than men (12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/11\">",
"     11",
"    </a>",
"    ]. HSV-2 seroprevalence was also three times greater among non-Hispanic blacks (39 percent) as among non-Hispanic whites (12 percent). Similar risk factors for HSV-2 positivity have been noted in other surveys [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/4,12-16\">",
"     4,12-16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TYPES OF INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical designations of genital herpes simplex virus (HSV) infection are: primary, nonprimary first episode, and recurrent (",
"    <a class=\"graphic graphic_table graphicRef80693 \" href=\"UTD.htm?9/63/10235\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Primary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary infection refers to infection in a patient without preexisting antibodies to either herpes simplex virus type 1 (HSV-1) or herpes simplex virus type 2 (HSV-2).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Nonprimary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonprimary first episode infection refers to the acquisition of genital HSV-1 in a patient with preexisting antibodies to HSV-2 or the acquisition of genital HSV-2 in a patient with preexisting antibodies to HSV-1 (eg, an individual with prior orolabial herpes and subsequent development of an HSV-1 antibody response develops genital herpes due to HSV-2 exposure).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Recurrent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent infection refers to reactivation of genital HSV in which the HSV type recovered in the lesion is the same type as antibodies in the serum.",
"   </p>",
"   <p>",
"    Each of these types can be either symptomatic or asymptomatic (also called subclinical). Asymptomatic infection will be detected only if the patient is tested by culture or polymerase chain reaction (PCR).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transmission of herpes simplex virus (HSV) may occur quickly in new sexual relationships. In a prospective study of 199 patients with newly acquired HSV genital infection, the median duration of the sexual relationship was 3.5 months (range 1.5 to 10 months) and the median number of sex acts before transmission was 40 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/17\">",
"     17",
"    </a>",
"    ]. Condom use was infrequent (50 percent during first intercourse; 20 percent during last intercourse before diagnosis). The median time to infection was greater in participants whose partners informed them that they had genital herpes than in those whose partners did not (270 versus 60 days).",
"   </p>",
"   <p>",
"    Transmission may also occur during periods of subclinical viral shedding (eg, when symptoms are absent). (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Viral shedding'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of genital herpes simplex virus (HSV) vary widely depending upon whether the infection is primary, nonprimary or recurrent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Primary infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of primary genital HSV infection are highly variable [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The initial presentation can be severe with painful genital ulcers, dysuria, fever, tender local inguinal lymphadenopathy, and headache. In other patients, however, the infection is mild, subclinical, or entirely asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/15,18\">",
"     15,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The average incubation period after exposure is four days (range two to twelve days) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/19\">",
"     19",
"    </a>",
"    ]. In one review, patients with primary infections usually had multiple, bilateral, ulcerating, pustular lesions which resolved after a mean of 19 days [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18\">",
"     18",
"    </a>",
"    ]. Symptoms tended to be more severe in women than in men. Other symptoms and signs in these first episode infections included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Systemic symptoms, including fever, headache, malaise, and myalgias (67 percent)",
"     </li>",
"     <li>",
"      Local pain and itching (98 percent)",
"     </li>",
"     <li>",
"      Dysuria (63 percent)",
"     </li>",
"     <li>",
"      Tender lymphadenopathy (80 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinician should differentiate dysuria from acute urinary retention, which can occur during severe primary HSV infection. Dysuria can lead to reluctance to void because of the passage of acidic urine on open and inflamed vesicles; this is best managed with Sitz baths. However, acute urinary retention with loss of sacral sensation can occur due to lumbosacral radiculomyelitis secondary to severe primary HSV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/20\">",
"     20",
"    </a>",
"    ]. This complication is transient, but usually requires catheterization until clinical improvement ensues.",
"   </p>",
"   <p>",
"    Primary genital herpes is commonly associated with viremia; of 164 adults with confirmed primary genital HSV infection, 40 (24 percent) had HSV DNA detected in plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/21\">",
"     21",
"    </a>",
"    ]. In one study, virus was isolated most commonly from the urethra and cervix of women with first episode infection (82 and 88 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18\">",
"     18",
"    </a>",
"    ]. Viral isolation was less frequent from the urethra in men (28 percent) and the pharynx in either women or men (13 and 7 percent, respectively). There are no clear differences in clinical presentation based on infecting virus (ie, HSV-1 versus HSV-2) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nonprimary infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonprimary first episode infection is associated with fewer lesions and less systemic symptoms than primary infection, presumably because antibodies against one HSV type offer some protection against the other [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. In one study, prior HSV-1 infection increased the likelihood of asymptomatic infection three-fold [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Recurrent infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical recurrences of genital HSV are common, but are typically less severe than primary or nonprimary infections. The mean duration of lesions is generally shorter with recurrences than in primary infection (10 versus 19 days) and the duration of viral shedding is usually two to five days [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/15,18,22\">",
"     15,18,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study that included a subset of 362 patients with recurrent infection, lesions were described as unilateral small vesicular or ulcerative lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18\">",
"     18",
"    </a>",
"    ]. Atypical vaginal lesions include fissures or vulvar irritation. Systemic symptoms are infrequent and approximately 25 percent of recurrent episodes are completely asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18\">",
"     18",
"    </a>",
"    ]. As many as 50 percent of patients with symptomatic recurrences have prodromal symptoms before eruption such as local mild tingling or shooting pains in the buttocks, legs, and hips [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors that contribute to decreased recurrences include infection with HSV-1 compared to HSV-2 and the duration and severity of the primary infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/15\">",
"     15",
"    </a>",
"    ]. Treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    does not influence recurrence rates [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EXTRAGENITAL COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extragenital complications occur in a minority of patients who present with primary herpes simplex virus (HSV) infection. In one study, extragenital complications included aseptic meningitis (8 percent), urinary bladder retention due to sacral autonomic nervous system dysfunction (2 percent), and distant skin lesions (20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18\">",
"     18",
"    </a>",
"    ]. Other series have noted higher rates of aseptic meningitis (25 percent) and urinary retention syndromes (10 to 15 percent) in women with primary infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/15\">",
"     15",
"    </a>",
"    ]. Transverse myelitis has been reported in immunosuppressed patients. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Immunosuppressed patients'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with HSV meningitis, the cerebrospinal fluid (CSF) profile includes a pleocytosis (median white cell count 300 to",
"    <span class=\"nowrap\">",
"     400/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </span>",
"    with a predominance of lymphocytes, and a normal CSF glucose concentration, although hypoglycorrhachia has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/18\">",
"     18",
"    </a>",
"    ]. HSV has been isolated from 0.5 to 3 percent of CSF samples from patients with aseptic meningitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=see_link\">",
"     \"Aseptic meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HSV-2 can also cause recurrent episodes of meningitis, called Mollaret's meningitis. Most patients do not have evidence of genital lesions at the time of presentation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=see_link&amp;anchor=H6#H6\">",
"     \"Aseptic meningitis in adults\", section on 'Herpes simplex meningitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=see_link&amp;anchor=H7#H7\">",
"     \"Aseptic meningitis in adults\", section on 'Recurrent (Mollaret's) meningitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Proctitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;HSV can also cause proctitis, particularly in men who have sex with men (MSM). The differential diagnosis of proctitis in MSM includes N. gonorrhoeae, herpes simplex virus, and Treponema pallidum infections. The frequency of these causes was evaluated in a review of 101 episodes of proctitis among MSM in San Francisco; anoscopy was performed and specimens obtained that were tested for the above organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/23\">",
"     23",
"    </a>",
"    ]. The following etiologies were noted in 55 percent of cases with a confirmed diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gonorrhea (20 percent)",
"     </li>",
"     <li>",
"      Herpes simplex (13 percent)",
"     </li>",
"     <li>",
"      Chlamydia (11 percent)",
"     </li>",
"     <li>",
"      Mixed infections (10 percent, including 3 percent with herpes)",
"     </li>",
"     <li>",
"      Syphilis (1 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     FREQUENCY OF RECURRENCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with primary genital herpes simplex virus (HSV) need to be counseled that recurrence is expected. The frequency of recurrence depends on the severity and duration of the initial episode, the infecting serotype, and the host.",
"   </p>",
"   <p>",
"    In one series of 457 patients with HSV-2 primary infection, 89 percent had one recurrence during a follow-up of 391 days [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/3\">",
"     3",
"    </a>",
"    ]. Furthermore, 38 percent of patients had as many as six recurrences and 20 percent had more than ten. Patients with primary infection lasting for five or more weeks experienced recurrences earlier and almost twice as often compared to those with a shorter duration of the initial infection.",
"   </p>",
"   <p>",
"    Recurrent infection is more common with HSV-2 than HSV-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/22,24\">",
"     22,24",
"    </a>",
"    ]. The magnitude of this effect was evaluated in a prospective study of 137 patients with a first symptomatic episode of genital herpes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/24\">",
"     24",
"    </a>",
"    ]. The likelihood of recurrence was much higher with HSV-2 infections (60 versus 14 percent with HSV-1). As a result, the proportion of episodes due to HSV-1 fell from 15 percent in primary first episodes to 2 percent in recurrent episodes.",
"   </p>",
"   <p>",
"    Recurrences are also more common in immunosuppressed patients. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Immunosuppressed patients'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     VIRAL SHEDDING",
"    </span>",
"    &nbsp;&mdash;&nbsp;After resolution of the primary genital herpes simplex virus (HSV) infection, asymptomatic intermittent viral shedding occurs in both men and women, even in the absence of genital lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/16,25-28\">",
"     16,25-28",
"    </a>",
"    ]. A prospective study of 498 immunocompetent HSV-2-seropositive persons demonstrated that HSV was shed more frequently in the 410 symptomatic persons compared with the 88 asymptomatic persons (20 percent versus 10 percent of days), although the quantities of virus were similar between the two groups [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/28\">",
"     28",
"    </a>",
"    ]. HSV genital shedding can also occur during a clinical outbreak primarily affecting the buttock region, which may reflect reactivation from sacral neural ganglia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/29\">",
"     29",
"    </a>",
"    ]. Subclinical HSV shedding is important since infection can be transmitted unknowingly to susceptible sexual partners and neonates. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Sex partners'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=see_link\">",
"     \"Genital herpes simplex virus infection and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The frequency of shedding is influenced by the infecting serotype, whether the infection is primary or nonprimary and the duration of time since the first clinical episode.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary genital HSV-2 infections have been linked to more frequent and prolonged asymptomatic viral shedding from the genitourinary tract compared to HSV-1 infections [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/7,22,24\">",
"       7,22,24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one study of 110 women with a median follow-up period of 105 days, viral shedding occurred on a mean of two percent of days, most often within seven days of a symptomatic recurrence, and was more likely to occur in patients with HSV-2 or mixed HSV-1 and HSV-2 infections compared to HSV-1 alone (55 and 52 versus 29 percent of patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A lower frequency of subclinical infection was noted in a cohort study of 306 women with a first episode of genital HSV infection [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/30\">",
"       30",
"      </a>",
"      ]. Asymptomatic viral shedding was detected among 18, 23, and 12 percent of women with primary HSV-2, nonprimary HSV-2, and primary HSV-1 genital infections, respectively. Asymptomatic cervical viral shedding was three times more frequent during the first three months following resolution of primary HSV-2 disease than at later time points and was consistently more common in patients with HSV-2 compared to HSV-1 genital infections.",
"     </li>",
"     <li>",
"      Time since the first genital HSV episode was significantly associated with reduced genital shedding in a study of 377 adults who self-collected anogenital swabs for HSV-2 DNA for a minimum of 30 consecutive days [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/31\">",
"       31",
"      </a>",
"      ]. The frequency of subclinical HSV shedding occurred in 26 percent of days among patients infected less than one year to 9 percent of days among those infected for more than 10 years. Although the frequency of subclinical shedding decreased, the quantity of virus remained stable over time, which may be associated with continued risk for transmission.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SEX PARTNERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have evaluated the risk of sexual transmission of genital herpes from index patients with recurrent herpes simplex virus (HSV) genital disease to susceptible partners [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. In one report, 144 heterosexual couples, in which the source partner had symptomatic recurrent genital HSV, were evaluated over a median of 334 days for development of culture-confirmed HSV infection or type-specific antibodies in the susceptible partner [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/32\">",
"     32",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transmission of genital HSV was documented in 14 couples (10 percent); the risk was greater with male than with female source partners (17 versus 4 percent).",
"     </li>",
"     <li>",
"      In susceptible women who lacked HSV-1 and HSV-2 antibodies at entry, the rate of acquiring genital herpes infections was higher than in women with preexisting HSV-1 antibodies (32 versus 9 percent)",
"     </li>",
"     <li>",
"      In 70 percent of patients, transmission of genital herpes was linked to sexual contact during periods of asymptomatic viral shedding. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Viral shedding'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A second smaller study confirmed these findings of a greater risk of HSV acquisition with male source partners and in patients without HSV antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     IMMUNOSUPPRESSED PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most genital herpes simplex virus (HSV) infections occurring in immunosuppressed adults reflect reactivation syndromes. The clinical presentation of symptomatic episodes may include extensive mucocutaneous involvement, variable appearance of genital lesions, and the development of chronic and recurrent ulcers. Recurrences are often more frequent, more extensive, and of longer duration than in immunocompetent patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. In addition, immunosuppressed patients may have prolonged viral shedding.",
"   </p>",
"   <p>",
"    A prospective trial evaluated 217 HIV-infected women who underwent twice yearly pelvic examination, including cultures of cervicovaginal specimens and swab specimens from genital lesions, if lesions were present [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/36\">",
"     36",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One-third had genital HSV-2 infection based upon history alone or positive culture results.",
"     </li>",
"     <li>",
"      Among these women, an HSV-2 culture was positive in one-third of visits; a positive culture was not associated with an apparent genital lesion approximately one-third of the time.",
"     </li>",
"     <li>",
"      Positive cultures occurred more frequently in patients with lower CD4 cell counts and higher plasma HIV-1 RNA levels. However, in one study, even optimum CD4 gains and viral suppression with ART did not eliminate the risk of significantly more genital lesions in HIV-infected women compared to controls [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to genital symptoms, neurologic complications occasionally develop and rapidly evolve in the setting of genital and mucocutaneous HSV infection occurring in transplant recipients and in HIV-infected patients with advanced disease. These complications include aseptic meningitis, sacral radiculopathy, and transverse myelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/38-40\">",
"     38-40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genital herpes simplex virus (HSV) infection is of particular concern in pregnant women because of the risk of transmission to the infant during delivery. This issue is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=see_link\">",
"     \"Genital herpes simplex virus infection and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     HSV-2 AND RISK OF HIV TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herpes simplex virus type 2 (HSV-2) genital ulcer disease has been definitively linked to an increased risk for acquisition of HIV-1 infection in regions with high seroprevalence rates of HSV-2 infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/41-51\">",
"     41-51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2002 meta-analysis of 31 studies was undertaken to assess the risk of acquiring HIV infection in HSV-2 seropositive individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/44\">",
"     44",
"    </a>",
"    ]. Depending upon the type of study, the risk estimate in HSV-2 seropositive individuals varied from 2.1 (95% CI 1.4-3.2) to 3.9 (95% CI 3.1-5.1). However, the temporal sequence of the two infections could not be determined.",
"   </p>",
"   <p>",
"    In a subsequent meta-analysis, 18 longitudinal studies were selected in which the relative timing of HSV-2 and HIV infections could be determined [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/52\">",
"     52",
"    </a>",
"    ]. This study demonstrated that prevalent HSV-2 infection was associated with a three-fold increased risk of HIV acquisition among both men and women in the general population. Modeling studies also demonstrate that HSV-2 epidemics could theoretically double the peak HIV incidence and create a \"core group\" of HIV transmitters in areas where HSV is highly prevalent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequent studies have underscored the relative importance of recent HSV infection, as compared to remote HSV infection, as a risk factor for HIV acquisition [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/43,49,53\">",
"     43,49,53",
"    </a>",
"    ]. In a pivotal seroepidemiologic study conducted in India, a cohort of 2732 HIV-seronegative patients (17 percent female) followed at sexually transmitted disease (STD) and reproductive tract clinics underwent HSV-2 antibody screening at baseline and were prospectively followed to assess for seroconversion to HIV-1 and HSV-2 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/43\">",
"     43",
"    </a>",
"    ]. The prevalence of HSV-2 at the time of enrollment was 43 percent, almost one-half of whom reported no history of genital ulcer disease. The following findings were noted during follow-up:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of HSV-2 and HIV infection was 11.4 cases and 5.8",
"      <span class=\"nowrap\">",
"       cases/100",
"      </span>",
"      person-years, respectively.",
"     </li>",
"     <li>",
"      The risk of acquiring HIV infection in this cohort was 3.6 percent for HSV-2 seronegative individuals at baseline, 7.5 percent for individuals with positive HSV-2 serology at baseline, and 22.6 percent for individuals with confirmed recent HSV-2 seroconversion within the past 6 months. The adjusted hazard ratios for HIV infection were 1.67 for HSV-2 infection at study entry, 1.92 for remote incident HSV-2 infection, and 3.81 for recent incident HSV-2 infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This association between HIV acquisition and HSV infection, particularly recent HSV infection, was confirmed in a nested case-control study in Tanzanian patients attending STD clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings underscore the need for effective HSV-2 interventions when implementing infection control strategies designed to limit HIV transmission. Clinical trials evaluating the impact of antiviral treatment of HSV-2 infected individuals with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/44/39622?source=see_link\">",
"     valacyclovir",
"    </a>",
"    on the incidence of HIV sexual transmission may provide pivotal information about how to implement interventional therapies on a global scale [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/48,50,54\">",
"     48,50,54",
"    </a>",
"    ]. There is also promising data on the use of an intravaginal gel that has antiviral activity against both HIV and HSV [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least three mechanisms may be important for the increase in HIV-1 transmission associated with sexual activity in patients with HSV-2 infection:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptomatic HSV-2 genital ulcers frequently cause local inflammation and mucosal disruption in the genital tract, which can facilitate HIV-1 entry during exposure to HIV-infected genital fluids [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Genital HSV-2 ulcers selectively increase local recruitment of CD4 positive cells, which may serve as targets for HIV-1 attachment in mucosal tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/56,57\">",
"       56,57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Replication competent virus has been isolated in HSV-2 lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with genital herpes who present with a genital ulcer, the primary differential diagnosis includes syphilis and chancroid among infectious causes, and drug eruptions and Beh&ccedil;et&rsquo;s disease among noninfectious causes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12538?source=see_link\">",
"     \"Approach to the patient with genital ulcers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A diagnosis based upon history and physical examination alone is often inaccurate [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/58\">",
"     58",
"    </a>",
"    ]. Therefore, the clinical diagnosis of genital herpes should be confirmed by laboratory testing. Nonetheless, some findings are more common in certain infections [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The classic presentation of genital herpes is with multiple, shallow, tender ulcers that may be vesicular; in addition, only herpes simplex virus (HSV) is associated with recurrent disease.",
"     </li>",
"     <li>",
"      The classic genital presentation of primary syphilis is with a painless, indurated, clean-based ulcer, called a chancre. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37017?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and treatment of early syphilis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The classic genital presentation of chancroid is with a deep, undermined, purulent ulcer that may be associated with painful inguinal lymphadenitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10696?source=see_link\">",
"       \"Chancroid\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A clinical diagnosis of genital herpes should be confirmed with laboratory testing [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/60\">",
"     60",
"    </a>",
"    ]. The classical presentation with multiple vesicles on an erythematous base is often absent in many patients. Thus, it is important to confirm the diagnosis of herpes simplex virus (HSV) infection with either of the following techniques: viral culture, polymerase chain reaction (PCR), direct fluorescence antibody, and type-specific serologic tests. The choice of test varies with the clinical presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/60\">",
"     60",
"    </a>",
"    ]. Cell culture and PCR-based testing are the preferred tests for a patient presenting with active lesions, although PCR-based testing has the greatest overall sensitivity and specificity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Viral culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;If active genital lesions are present, the vesicle should be unroofed for sampling of vesicular fluid for culture. However, the overall sensitivity of viral culture of genital lesions is only approximately 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. The diagnostic yield of culture is highest in the early stages of disease, when lesions are typically vesicular, and declines rapidly as the lesions begin to heal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/63\">",
"     63",
"    </a>",
"    ]. Viral isolation rates are also higher with primary compared to recurrent genital herpes, particularly in the setting of asymptomatic recurrences with subclinical shedding.",
"   </p>",
"   <p>",
"    Specimens for culture should be directly placed in viral culture media and rapidly transported to the laboratory. Viral isolates usually grow in tissue culture by five days and are typed by antibody staining.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;While viral culture has remained the standard diagnostic method for isolating HSV, real-time HSV PCR assays have emerged as a more sensitive method to confirm HSV infection in clinical specimens obtained from genital ulcers and mucocutaneous sites; PCR is the test of choice for cerebrospinal fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/2,64-67\">",
"     2,64-67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PCR is particularly useful for the detection of asymptomatic HSV shedding. It has also been used in clinical studies to evaluate the risk of transmission in discordant couples and the effectiveness of suppression with antiviral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/32/7690?source=see_link\">",
"     \"Treatment of genital herpes simplex virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The enhanced sensitivity of HSV PCR compared to viral culture can be illustrated by the following observations from different studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HSV DNA levels with PCR testing were 250 times higher from culture-positive compared to culture-negative samples [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among women with recurrent genital herpes who underwent daily sampling of genital lesions, HSV DNA was detected in ulcerative lesions on 15 of 17 days compared to only 3 of 17 days by viral isolation [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A randomized trial compared",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/44/39622?source=see_link\">",
"       valacyclovir",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"       acyclovir",
"      </a>",
"      , and placebo for suppression of HSV shedding in the genital tract [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/69\">",
"       69",
"      </a>",
"      ]. During the placebo period, both the lesional HSV shedding rate (87 versus 47 percent of days) and the asymptomatic shedding rate (27 versus 7 percent of days) were significantly higher with PCR than with culture. The higher sensitivity of PCR compared to culture was also confirmed in the treatment phase of the study.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Earlier diagnosis by real-time HSV PCR assays may also reduce the transmission of infection during reactivation syndromes that are manifested only by asymptomatic viral shedding [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/61,63,70\">",
"     61,63,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further development of this assay now allows differentiation of HSV-1 and HSV-2 using real-time TaqMan PCR techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/71\">",
"     71",
"    </a>",
"    ]. The main limiting factor in adopting real-time HSV PCR as the primary diagnostic tool in many clinical reference laboratories is the cost of the assay, which substantially exceeds that of viral isolation culture techniques. In addition, the lack of uniform validation of the PCR assay as a diagnostic method for detecting HSV in clinical specimens other than cerebrospinal fluid has limited its availability in some commercial laboratories [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1801546\">",
"    <span class=\"h2\">",
"     Direct fluorescent antibody",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many diagnostic laboratories provide a rapid type-specific direct fluorescent antibody (DFA) test to detect HSV in clinical specimens. This test is specific and reproducible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type specific antibodies to HSV develop during the first several weeks after infection and persist indefinitely [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/58\">",
"     58",
"    </a>",
"    ]. The availability of type-specific antibody testing has facilitated greater accuracy in epidemiologic surveys. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Interpretation and use of serologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several FDA-approved type-specific HSV serologic tests are commercially available to clinicians evaluating genital ulcer disease in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/58,72-74\">",
"     58,72-74",
"    </a>",
"    ]. Serologic testing for HSV-1 and HSV-2 can be used to [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnose a patient with a history of genital lesions who did not have a diagnostic workup.",
"     </li>",
"     <li>",
"      Diagnose a past or present HSV infection in a patient with an atypical presentation.",
"     </li>",
"     <li>",
"      Determine susceptibility of a sexual partner of a patient with documented genital HSV infection.",
"     </li>",
"     <li>",
"      Identify asymptomatic HSV infection in pregnant women who are at risk for shedding at the time of delivery with potential transmission to the infant. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=see_link\">",
"       \"Genital herpes simplex virus infection and pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Help predict the risk of recurrence. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Frequency of recurrences'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The availability of type-specific serology using surface glycoproteins (gG2 and gG1 for HSV-2 and HSV-1, respectively) to distinguish HSV-1 and HSV-2 enables the clinician to determine if the patient is at risk of acquisition or has evidence of prior infection with either subtype [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/26,75\">",
"     26,75",
"    </a>",
"    ]. A positive serology indicates present or past infection; IgM antibody testing is not useful for discriminating primary versus recurrent episodes of HSV infection. Since genital ulcers have many possible etiologies, a positive HSV IgG antibody serology cannot be used for diagnosis of an active genital ulcer without further diagnostic evaluation. In contrast, a positive culture for HSV in a HSV seronegative patient is strong evidence of primary infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/60\">",
"     60",
"    </a>",
"    ]. Positive serologic testing for HSV-2 indicates anogenital infection, but positive serologic testing for HSV-1 can be consistent with either anogenital or orolabial infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12538?source=see_link\">",
"     \"Approach to the patient with genital ulcers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Types of serologic testing",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surface glycoproteins &mdash; The sensitivities of glycoprotein G type-specific tests vary from 80 to 98 percent and false negative results may occur at early stages of infection; the specificity of these assays is greater than 96 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Rapid serologic testing &mdash; The rapid test has a sensitivity and specificity of 97 and 98 percent, respectively, and positive and negative predictive values of 92 and 99 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/76\">",
"       76",
"      </a>",
"      ]. Rapid testing can be completed in 15 minutes at the point of care. Rapid serologic testing may be useful in developing countries where HSV-2 prevalence is high and resource limitations preclude other types of laboratory testing [",
"      <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/77\">",
"       77",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Tzanck smear",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Tzanck smear, which may demonstrate the cytopathic effect of the virus (multinucleate giant cells), can be performed on lesion scrapings from patients with active genital lesions. However, it has limited utility since it has low sensitivity and specificity and is only helpful if positive [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/78\">",
"     78",
"    </a>",
"    ]. Furthermore, only a viral culture or PCR-based testing can determine whether the infection is due to HSV-1 or HSV-2.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relatively high seroprevalence rate of herpes simplex virus type 2 (HSV-2) infection in the United States (22 percent in persons &ge;12 years of age between 1988 and 1994) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/14\">",
"     14",
"    </a>",
"    ] and the risk of transmission to sexual partners has raised the question of whether serologic screening may be justified in asymptomatic sexually active individuals. At present, routine screening for HSV-2 is",
"    <strong>",
"     not",
"    </strong>",
"    recommended because there may be a relatively high false positive rate in low risk populations, which could create uncertainty in the absence of formal guidelines about how to reconcile the test results [",
"    <a class=\"abstract\" href=\"UTD.htm?9/10/9386/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to the possible role of screening in pregnant women are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=see_link\">",
"     \"Genital herpes simplex virus infection and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21906?source=see_link\">",
"       \"Patient information: Genital herpes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/3/36916?source=see_link\">",
"       \"Patient information: Genital herpes (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Herpes simplex virus (HSV) is a common sexually transmitted disease worldwide. Although HSV-2 has historically been the main causative agent for the preponderance of virologically confirmed infections, HSV-1 is associated with an increasing proportion of cases of genital herpes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical designations of genital HSV infection are: primary, nonprimary first episode, and recurrent infection. Primary infection refers to infection in a patient without preexisting antibodies to either HSV-1 or HSV-2. Nonprimary first episode infection refers to the acquisition of genital HSV-1 in a patient with preexisting antibodies to the alternate serotype. Recurrent infection refers to reactivation of genital HSV in which the HSV type recovered in the lesion is the same type as those seen on serologic testing. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Types of infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transmission of HSV may occur quickly in new sexual relationships. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations of primary genital HSV infection are highly variable. The initial presentation can be severe with painful genital ulcers and constitutional symptoms; in other patients, the infection may be mild or entirely asymptomatic. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonprimary first episode infection is associated with fewer lesions and less systemic symptoms than primary infection, presumably because antibodies against one HSV type offer some protection against the other.",
"     </li>",
"     <li>",
"      Clinical recurrences of genital HSV are common, but are typically less severe than primary or nonprimary infections.",
"     </li>",
"     <li>",
"      Extragenital complications, like aseptic meningitis and urinary retention, occur in a minority of patients who present with primary HSV infection. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Extragenital complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The frequency of recurrence depends on the severity and duration of the initial episode, the infecting serotype, and the host. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Recurrent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After resolution of the primary genital HSV infection, asymptomatic intermittent viral shedding has been documented in both men and women in the absence of genital lesions. Subclinical HSV shedding is important since infection can be transmitted unknowingly to susceptible sexual partners and neonates. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Viral shedding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among susceptible sexual partners, there is a greater risk of HSV acquisition with male source partners and in patients without HSV antibodies. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Sex partners'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In immunosuppressed patients, most genital HSV infections occurring in immunosuppressed adults reflect reactivation syndromes. Symptomatic episodes may more severe, frequent, and longer in duration. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Immunosuppressed patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HSV-2 genital ulcer disease has been definitively linked to an increased risk for acquisition of HIV-1 infection in regions with high seroprevalence rates of HSV-2 infection. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'HSV-2 and risk of HIV transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of HSV infection can be confirmed by polymerase chain reaction (PCR), viral culture, and type-specific serologic tests. The choice of test varies with the clinical presentation. PCR-based assays or culture are preferred for active genital lesions; serologic testing is the preferred method in patients without active disease. PCR is the most sensitive test available, but is limited by cost. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine screening for HSV-1 or HSV-2 infection by serologic testing is not recommended. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/1\">",
"      Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/std/treatment/2010/default.htm (Accessed on January 07, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/3\">",
"      Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994; 121:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/4\">",
"      Bernstein DI, Bellamy AR, Hook EW 3rd, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013; 56:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/5\">",
"      Schillinger JA, McKinney CM, Garg R, et al. Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sex Transm Dis 2008; 35:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/6\">",
"      Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/7\">",
"      Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993; 69:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/8\">",
"      Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/9\">",
"      Jin F, Prestage GP, Mao L, et al. Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV-negative gay men: the health in men study. J Infect Dis 2006; 194:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/10\">",
"      Sucato G, Wald A, Wakabayashi E, et al. Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. J Infect Dis 1998; 177:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/11\">",
"      Centers for Disease Control and Prevention (CDC). Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2010; 59:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/12\">",
"      Cowan FM, Johnson AM, Ashley R, et al. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996; 174:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/13\">",
"      Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/14\">",
"      Arvin AM, Prober CG. Herpes simplex virus type 2--a persistent problem. N Engl J Med 1997; 337:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/15\">",
"      Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998; 26:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/16\">",
"      Sizemore JM Jr, Lakeman F, Whitley R, et al. The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2006; 193:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/17\">",
"      Wald A, Krantz E, Selke S, et al. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006; 194:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/18\">",
"      Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/19\">",
"      Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med 2004; 350:1970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/20\">",
"      Eberhardt O, K&uuml;ker W, Dichgans J, Weller M. HSV-2 sacral radiculitis (Elsberg syndrome). Neurology 2004; 63:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/21\">",
"      Johnston C, Magaret A, Selke S, et al. Herpes simplex virus viremia during primary genital infection. J Infect Dis 2008; 198:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/22\">",
"      Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/23\">",
"      Klausner JD, Kohn R, Kent C. Etiology of clinical proctitis among men who have sex with men. Clin Infect Dis 2004; 38:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/24\">",
"      Reeves WC, Corey L, Adams HG, et al. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med 1981; 305:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/25\">",
"      Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/26\">",
"      Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992; 326:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/27\">",
"      Mark KE, Wald A, Magaret AS, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 2008; 198:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/28\">",
"      Tronstein E, Johnston C, Huang ML, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011; 305:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/29\">",
"      Kerkering K, Gardella C, Selke S, et al. Isolation of herpes simplex virus from the genital tract during symptomatic recurrence on the buttocks. Obstet Gynecol 2006; 108:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/30\">",
"      Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992; 116:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/31\">",
"      Phipps W, Saracino M, Magaret A, et al. Persistent genital herpes simplex virus-2 shedding years following the first clinical episode. J Infect Dis 2011; 203:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/32\">",
"      Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/33\">",
"      Bryson Y, Dillon M, Bernstein DI, et al. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993; 167:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/34\">",
"      Foley E, Patel R. Treatment of genital herpes infections in HIV-infected patients. J HIV Ther 2004; 9:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/35\">",
"      Severson JL, Tyring SK. Relation between herpes simplex viruses and human immunodeficiency virus infections. Arch Dermatol 1999; 135:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/36\">",
"      Wright PW, Hoesley CJ, Squires KE, et al. A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level. Clin Infect Dis 2003; 36:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/37\">",
"      Ameli N, Bacchetti P, Morrow RA, et al. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS 2006; 20:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/38\">",
"      Momm&eacute;ja-Marin H, Lafaurie M, Scieux C, et al. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis 2003; 37:1527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/39\">",
"      Corral I, Quereda C, Navas E, et al. Sacral myeloradiculitis complicating genital herpes in a HIV-infected patient. Int J STD AIDS 2005; 16:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/40\">",
"      Yoritaka A, Ohta K, Kishida S. Herpetic lumbosacral radiculoneuropathy in patients with human immunodeficiency virus infection. Eur Neurol 2005; 53:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/41\">",
"      Schacker T, Ryncarz AJ, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/42\">",
"      Telzak EE, Chiasson MA, Bevier PJ, et al. HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993; 119:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/43\">",
"      Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/44\">",
"      Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/45\">",
"      Krone MR, Wald A, Tabet SR, et al. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/46\">",
"      Schacker T, Zeh J, Hu HL, et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 1998; 178:1616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/47\">",
"      Mbopi-K&eacute;ou FX, Gr&eacute;senguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/48\">",
"      Blower S, Ma L. Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin Infect Dis 2004; 39 Suppl 5:S240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/49\">",
"      Todd J, Grosskurth H, Changalucha J, et al. Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. J Infect Dis 2006; 193:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/50\">",
"      Bartlett JG. Recent developments in the management of herpes simplex virus infection in HIV-infected persons. Clin Infect Dis 2004; 39 Suppl 5:S237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/51\">",
"      Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 2008; 65:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/52\">",
"      Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/53\">",
"      Kapiga SH, Sam NE, Bang H, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis 2007; 195:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/54\">",
"      Celum CL, Robinson NJ, Cohen MS. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005; 191 Suppl 1:S107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/55\">",
"      Keller MJ, Zerhouni-Layachi B, Cheshenko N, et al. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. J Infect Dis 2006; 193:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/56\">",
"      Koelle DM, Abbo H, Peck A, et al. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis 1994; 169:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/57\">",
"      Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2007; 21:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/58\">",
"      Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/59\">",
"      DiCarlo RP, Martin DH. The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 1997; 25:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/60\">",
"      Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370:2127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/61\">",
"      Schomogyi M, Wald A, Corey L. Herpes simplex virus-2 infection. An emerging disease? Infect Dis Clin North Am 1998; 12:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/62\">",
"      Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987; 316:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/63\">",
"      Moseley RC, Corey L, Benjamin D, et al. Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol 1981; 13:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/64\">",
"      Ramaswamy M, McDonald C, Smith M, et al. Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect 2004; 80:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/65\">",
"      Fil&eacute;n F, Strand A, Allard A, et al. Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sex Transm Dis 2004; 31:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/66\">",
"      Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1996; 174:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/67\">",
"      Strick LB, Wald A. Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol Diagn Ther 2006; 10:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/68\">",
"      Cone RW, Hobson AC, Palmer J, et al. Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J Infect Dis 1991; 164:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/69\">",
"      Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004; 190:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/70\">",
"      Cone RW, Hobson AC, Brown Z, et al. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 1994; 272:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/71\">",
"      Corey L, Huang ML, Selke S, Wald A. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol 2005; 76:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/72\">",
"      Ashley RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect 2001; 77:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/73\">",
"      Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002; 35:S173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/74\">",
"      Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal 2000; 14:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/75\">",
"      Whittington WL, Celum CL, Cent A, Ashley RL. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics. Sex Transm Dis 2001; 28:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/76\">",
"      Philip SS, Ahrens K, Shayevich C, et al. Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection. Clin Infect Dis 2008; 47:e79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/77\">",
"      Ashley-Morrow R, Nollkamper J, Robinson NJ, et al. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/78\">",
"      Sen P, Barton SE. Genital herpes and its management. BMJ 2007; 334:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/10/9386/abstract/79\">",
"      Krantz I, L&ouml;whagen GB, Ahlberg BM, Nilstun T. Ethics of screening for asymptomatic herpes virus type 2 infection. BMJ 2004; 329:618.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8347 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-37B631BF3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9386=[""].join("\n");
var outline_f9_10_9386=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TYPES OF INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Primary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Nonprimary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Recurrent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Primary infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nonprimary infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Recurrent infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EXTRAGENITAL COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Proctitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      FREQUENCY OF RECURRENCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      VIRAL SHEDDING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SEX PARTNERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      IMMUNOSUPPRESSED PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      HSV-2 AND RISK OF HIV TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Viral culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1801546\">",
"      Direct fluorescent antibody",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Interpretation and use of serologic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Types of serologic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Tzanck smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8347\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8347|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/63/10235\" title=\"table 1\">",
"      Designation of genital HSV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12538?source=related_link\">",
"      Approach to the patient with genital ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=related_link\">",
"      Aseptic meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10696?source=related_link\">",
"      Chancroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=related_link\">",
"      Genital herpes simplex virus infection and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37017?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of early syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/3/36916?source=related_link\">",
"      Patient information: Genital herpes (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21906?source=related_link\">",
"      Patient information: Genital herpes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/15/21751?source=related_link\">",
"      Prevention of genital herpes virus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/32/7690?source=related_link\">",
"      Treatment of genital herpes simplex virus infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_10_9387="Somatropic axis HIV";
var content_f9_10_9387=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Alterations in the somatotropic axis in HIV infection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        HIV-infected, no wasting or lipodystrophy",
"       </td>",
"       <td class=\"subtitle1\">",
"        HIV-infected, lipodystrophy",
"       </td>",
"       <td class=\"subtitle1\">",
"        AIDS wasting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GH",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IGF-1",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IGF-BP-3",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal or &darr;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GH: growth hormone; IGF-1: insulin-like growth factor-1; IGF-BP-3: insulin-like growth factor-binding protein-3.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9387=[""].join("\n");
var outline_f9_10_9387=null;
var title_f9_10_9388="Unique fracture terms";
var content_f9_10_9388=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Unique fracture terms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Finger",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mallet finger",
"       </td>",
"       <td>",
"        Rupture of distal extensor tendon that may involve avulsion fracture of distal phalanx",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Jersey finger",
"       </td>",
"       <td>",
"        Rupture of distal flexor tendon that may involve avulsion fracture of distal phalanx",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Boxer's fracture",
"       </td>",
"       <td>",
"        Fracture of distal 5th metacarpal at the metaphyseal-diaphyseal junction with apex dorsal angulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Wrist",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Colles fracture",
"       </td>",
"       <td>",
"        Distal radius fracture with apex palmar angulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Smith's fracture",
"       </td>",
"       <td>",
"        Distal radius fracture with apex dorsal angulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Styloid fracture",
"       </td>",
"       <td>",
"        Fracture of the distal radius or distal ulna styloid process",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Hip",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Femoral neck fracture",
"       </td>",
"       <td>",
"        Proximal femur fracture between the trochanters and the femoral head",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intertrochanteric fracture",
"       </td>",
"       <td>",
"        Proximal femur fracture extending between the greater and lesser trochanters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Foot",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Jones fracture",
"       </td>",
"       <td>",
"        Acute fracture in the metaphyseal-diaphyseal area of the proximal 5th metatarsal (often confused with avulsion or stress fractures)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: McGowan HJ. In: Sports Medicine Resource Manual, 1st ed, Seidenberg P, Beutler AI (Eds), Saunders, Philadelphia, 2007, p.147-51. Illustration used with permission of Elsevier Inc. All rights reserved. Copyright &copy; 2007 Elsevier Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9388=[""].join("\n");
var outline_f9_10_9388=null;
var title_f9_10_9389="AASLD diagnosis screening Wilson";
var content_f9_10_9389=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    AASLD recommendations for diagnosis and screening for Wilson disease (WD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Clinical features:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       WD should be considered in any individual between the ages of 3 and 55* years with liver abnormalities of uncertain cause. Age alone should not be the basis for eliminating a diagnosis of WD.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       WD must be excluded in any patient with unexplained liver disease along with neurological or neuropsychiatric disorder.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       In a patient in whom WD is suspected, Kayser-Fleischer rings should be sought by slit-lamp examination by a skilled examiner. The absence of Kayser-Fleischer rings does not exclude the diagnosis of WD, even in patients with predominantly neurological disease.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Diagnostic testing:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       An extremely low serum ceruloplasmin level (&lt;50 mg/L or &lt;5 mg/dL) should be taken as strong evidence for the diagnosis of WD. Modestly subnormal levels suggest further evaluation is necessary. Serum ceruloplasmin within the normal range does not exclude the diagnosis.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Basal 24-hour urinary excretion of copper should be obtained in all patients in whom the diagnosis of WD is being considered. The amount of copper excreted in the 24-hour period is typically &gt;100 mcg (1.6 micromol) in symptomatic patients, but finding &gt;40 mcg (&gt;0.6 micromol or &gt;600 nmol) may indicate WD and requires further investigation.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Penicillamine challenge studies may be performed for the purpose of obtaining further evidence for the diagnosis of WD in symptomatic children if basal urinary copper excretion is &lt;100 mcg/24 hours (1.6 micromol/24 hours). Values for the penicillamine challenge test of &gt;1600 mcg copper/24 hours (&gt;25 micromol/24 hours) following the administration of 500 mg of D-penicillamine at the beginning and again 12 hours later during the 24-hour urine collection are found in patients with Wilson disease. The predictive value of this test in adults is unknown.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hepatic parenchymal copper content &gt;250 mcg/g dry weight provides critical diagnostic information and should be obtained in cases where the diagnosis is not straightforward and in younger patients. In untreated patients, normal hepatic copper content (&lt;40-50 mcg/g dry weight) almost always excludes a diagnosis of WD. Further diagnostic testing is indicated for patients with intermediate copper concentrations (70-250 mcg/g dry weight) especially if there is active liver disease or other symptoms of WD.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neurologic evaluation and radiologic imaging of the brain, preferably by MR imaging, should be considered prior to treatment in all patients with neurologic WD and should be part of the evaluation of any patient presenting with neurological symptoms consistent with WD.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mutation analysis by whole-gene sequencing is possible and should be performed on individuals in whom the diagnosis is difficult to establish by clinical and biochemical testing. Haplotype analysis or specific testing for known mutations can be used for family screening of first-degree relatives of patients with WD. A clinical geneticist may be required to interpret the results.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Diagnostic considerations in specific target populations:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Patients in the pediatric age bracket who present a clinical picture of autoimmune hepatitis should be investigated for WD.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Adult patients with atypical autoimmune hepatitis or who respond poorly to standard corticosteroid therapy should also be investigated for WD.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       WD should be considered in the differential diagnosis of patients presenting with nonalcoholic fatty liver disease or have pathologic findings of nonalcoholic steatohepatitis.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       WD should be suspected in any patient presenting with acute hepatic failure with Coombs-negative intravascular hemolysis, modest elevations in serum aminotransferases, or low serum alkaline phosphatase and ratio of alkaline phosphatase to bilirubin of &lt;2.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       First-degree relatives of any patient newly diagnosed with WD must be screened for WD.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *Wilson disease has been diagnosed in patients in their seventies.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47:2089.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9389=[""].join("\n");
var outline_f9_10_9389=null;
var title_f9_10_9390="Sieving Coefficients for Drugs";
var content_f9_10_9390=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hemofiltration sieving coefficients for drugs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            &nbsp;",
"           </td>",
"           <td class=\"subtitle1\">",
"            SC",
"           </td>",
"           <td class=\"subtitle1\">",
"            Unbound fraction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_left\" colspan=\"3\">",
"            Antimicrobials",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acyclovir",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Amikacin",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Amphotericin",
"           </td>",
"           <td>",
"            0.3",
"           </td>",
"           <td>",
"            0.1",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ampicillin",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cefoperazone",
"           </td>",
"           <td>",
"            0.3",
"           </td>",
"           <td>",
"            0.1",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cefoxitin",
"           </td>",
"           <td>",
"            0.6",
"           </td>",
"           <td>",
"            0.5",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ceftazidime",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ciprofloxacin",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ganciclovir",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            1.0",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Gentamicin",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Imipenem",
"           </td>",
"           <td>",
"            1.0",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Jazobactam",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Levofloxacin",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Linezolid",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Metronidazole",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Mezlocillin",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ofloxacin",
"           </td>",
"           <td>",
"            0.3",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Oxacillin",
"           </td>",
"           <td>",
"            0.02",
"           </td>",
"           <td>",
"            0.05",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Penicillin",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"           <td>",
"            0.5",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Piperacillin",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sulfamethoxazole",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.6",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Vancomycin",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            &nbsp;",
"           </td>",
"           <td class=\"subtitle1\">",
"            SC",
"           </td>",
"           <td class=\"subtitle1\">",
"            Unbound fraction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_left\" colspan=\"3\">",
"            Other drugs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cyclosporine",
"           </td>",
"           <td>",
"            0.6",
"           </td>",
"           <td>",
"            0.1",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Diazepam",
"           </td>",
"           <td>",
"            0.02",
"           </td>",
"           <td>",
"            0.02",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Digitoxin",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Digoxin",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Famotidine",
"           </td>",
"           <td>",
"            0.7",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Glutethimide",
"           </td>",
"           <td>",
"            0.02",
"           </td>",
"           <td>",
"            0.5",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lidocaine",
"           </td>",
"           <td>",
"            0.2",
"           </td>",
"           <td>",
"            0.4",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Metamizole",
"           </td>",
"           <td>",
"            0.4",
"           </td>",
"           <td>",
"            0.4",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Oxazepam",
"           </td>",
"           <td>",
"            0.1",
"           </td>",
"           <td>",
"            0.1",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Phenobarbital",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.6",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Phenytoin",
"           </td>",
"           <td>",
"            0.4",
"           </td>",
"           <td>",
"            0.2",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Procainamide",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ranitidine",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"           <td>",
"            0.8",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Theophylline",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"           <td>",
"            0.9",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Sieving coefficient (SC) and unbound fraction for some commonly used drugs. There is usually a close correlation between these parameters because only the free or unbound drug is available for removal by hemofiltration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9390=[""].join("\n");
var outline_f9_10_9390=null;
var title_f9_10_9391="Abdominal crunches exercise";
var content_f9_10_9391=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F80909&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F80909&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Abdominal crunches",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 155px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With arms at sides, the patient tilts the pelvis to flatten the back. The shoulder and the head are then raised from the floor. If necessary, the arms may be used to support the trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_10_9391=[""].join("\n");
var outline_f9_10_9391=null;
